id	sid	tid	token	lemma	pos
ajlm-1264	1	1	abstract	abstract	ADJ
ajlm-1264	1	2	introduction	introduction	NOUN
ajlm-1264	1	3	methods	method	NOUN
ajlm-1264	1	4	results	result	VERB
ajlm-1264	1	5	discussion	discussion	NOUN
ajlm-1264	1	6	acknowledgements	acknowledgement	NOUN
ajlm-1264	1	7	references	reference	NOUN
ajlm-1264	1	8	about	about	ADP
ajlm-1264	1	9	the	the	DET
ajlm-1264	1	10	author(s	author(s	NOUN
ajlm-1264	1	11	)	)	PUNCT
ajlm-1264	1	12	faithful	faithful	ADJ
ajlm-1264	1	13	makita	makita	PROPN
ajlm-1264	1	14	-	-	PUNCT
ajlm-1264	1	15	chingombe	chingombe	PROPN
ajlm-1264	1	16	international	international	ADJ
ajlm-1264	1	17	pharmacology	pharmacology	NOUN
ajlm-1264	1	18	specialty	specialty	NOUN
ajlm-1264	1	19	laboratory	laboratory	NOUN
ajlm-1264	1	20	,	,	PUNCT
ajlm-1264	1	21	school	school	NOUN
ajlm-1264	1	22	of	of	ADP
ajlm-1264	1	23	pharmacy	pharmacy	NOUN
ajlm-1264	1	24	,	,	PUNCT
ajlm-1264	1	25	university	university	NOUN
ajlm-1264	1	26	of	of	ADP
ajlm-1264	1	27	zimbabwe	zimbabwe	PROPN
ajlm-1264	1	28	college	college	PROPN
ajlm-1264	1	29	of	of	ADP
ajlm-1264	1	30	health	health	PROPN
ajlm-1264	1	31	sciences	sciences	PROPN
ajlm-1264	1	32	,	,	PUNCT
ajlm-1264	1	33	harare	harare	PROPN
ajlm-1264	1	34	,	,	PUNCT
ajlm-1264	1	35	zimbabwe	zimbabwe	PROPN
ajlm-1264	1	36	anthony	anthony	PROPN
ajlm-1264	1	37	t.	t.	PROPN
ajlm-1264	1	38	podany	podany	PROPN
ajlm-1264	1	39	antiviral	antiviral	ADJ
ajlm-1264	1	40	pharmacology	pharmacology	NOUN
ajlm-1264	1	41	laboratory	laboratory	NOUN
ajlm-1264	1	42	,	,	PUNCT
ajlm-1264	1	43	university	university	PROPN
ajlm-1264	1	44	of	of	ADP
ajlm-1264	1	45	nebraska	nebraska	PROPN
ajlm-1264	1	46	medical	medical	ADJ
ajlm-1264	1	47	center	center	PROPN
ajlm-1264	1	48	,	,	PUNCT
ajlm-1264	1	49	omaha	omaha	PROPN
ajlm-1264	1	50	,	,	PUNCT
ajlm-1264	1	51	nebraska	nebraska	PROPN
ajlm-1264	1	52	,	,	PUNCT
ajlm-1264	1	53	united	united	PROPN
ajlm-1264	1	54	states	states	PROPN
ajlm-1264	1	55	timothy	timothy	PROPN
ajlm-1264	1	56	mykris	mykris	PROPN
ajlm-1264	1	57	antiviral	antiviral	ADJ
ajlm-1264	1	58	pharmacology	pharmacology	NOUN
ajlm-1264	1	59	laboratory	laboratory	NOUN
ajlm-1264	1	60	,	,	PUNCT
ajlm-1264	1	61	university	university	PROPN
ajlm-1264	1	62	of	of	ADP
ajlm-1264	1	63	nebraska	nebraska	PROPN
ajlm-1264	1	64	medical	medical	ADJ
ajlm-1264	1	65	center	center	PROPN
ajlm-1264	1	66	,	,	PUNCT
ajlm-1264	1	67	omaha	omaha	PROPN
ajlm-1264	1	68	,	,	PUNCT
ajlm-1264	1	69	nebraska	nebraska	PROPN
ajlm-1264	1	70	,	,	PUNCT
ajlm-1264	1	71	united	united	PROPN
ajlm-1264	1	72	states	states	PROPN
ajlm-1264	1	73	farai	farai	NUM
ajlm-1264	1	74	muzambi	muzambi	PROPN
ajlm-1264	1	75	international	international	PROPN
ajlm-1264	1	76	pharmacology	pharmacology	NOUN
ajlm-1264	1	77	specialty	specialty	NOUN
ajlm-1264	1	78	laboratory	laboratory	NOUN
ajlm-1264	1	79	,	,	PUNCT
ajlm-1264	1	80	school	school	NOUN
ajlm-1264	1	81	of	of	ADP
ajlm-1264	1	82	pharmacy	pharmacy	NOUN
ajlm-1264	1	83	,	,	PUNCT
ajlm-1264	1	84	university	university	NOUN
ajlm-1264	1	85	of	of	ADP
ajlm-1264	1	86	zimbabwe	zimbabwe	PROPN
ajlm-1264	1	87	college	college	PROPN
ajlm-1264	1	88	of	of	ADP
ajlm-1264	1	89	health	health	PROPN
ajlm-1264	1	90	sciences	sciences	PROPN
ajlm-1264	1	91	,	,	PUNCT
ajlm-1264	1	92	harare	harare	PROPN
ajlm-1264	1	93	,	,	PUNCT
ajlm-1264	1	94	zimbabwe	zimbabwe	PROPN
ajlm-1264	1	95	richard	richard	PROPN
ajlm-1264	1	96	w.	w.	PROPN
ajlm-1264	1	97	browne	browne	PROPN
ajlm-1264	1	98	translational	translational	PROPN
ajlm-1264	1	99	pharmacology	pharmacology	NOUN
ajlm-1264	1	100	research	research	NOUN
ajlm-1264	1	101	core	core	NOUN
ajlm-1264	1	102	,	,	PUNCT
ajlm-1264	1	103	center	center	NOUN
ajlm-1264	1	104	for	for	ADP
ajlm-1264	1	105	integrated	integrate	VERB
ajlm-1264	1	106	global	global	ADJ
ajlm-1264	1	107	biomedical	biomedical	ADJ
ajlm-1264	1	108	sciences	science	NOUN
ajlm-1264	1	109	,	,	PUNCT
ajlm-1264	1	110	school	school	NOUN
ajlm-1264	1	111	of	of	ADP
ajlm-1264	1	112	pharmacy	pharmacy	NOUN
ajlm-1264	1	113	and	and	CCONJ
ajlm-1264	1	114	pharmaceutical	pharmaceutical	NOUN
ajlm-1264	1	115	sciences	science	NOUN
ajlm-1264	1	116	,	,	PUNCT
ajlm-1264	1	117	university	university	NOUN
ajlm-1264	1	118	at	at	ADP
ajlm-1264	1	119	buffalo	buffalo	PROPN
ajlm-1264	1	120	,	,	PUNCT
ajlm-1264	1	121	buffalo	buffalo	PROPN
ajlm-1264	1	122	,	,	PUNCT
ajlm-1264	1	123	new	new	PROPN
ajlm-1264	1	124	york	york	PROPN
ajlm-1264	1	125	,	,	PUNCT
ajlm-1264	1	126	united	united	PROPN
ajlm-1264	1	127	states	states	PROPN
ajlm-1264	1	128	andrew	andrew	PROPN
ajlm-1264	1	129	j.	j.	PROPN
ajlm-1264	1	130	ocque	ocque	PROPN
ajlm-1264	1	131	translational	translational	PROPN
ajlm-1264	1	132	pharmacology	pharmacology	NOUN
ajlm-1264	1	133	research	research	NOUN
ajlm-1264	1	134	core	core	NOUN
ajlm-1264	1	135	,	,	PUNCT
ajlm-1264	1	136	center	center	NOUN
ajlm-1264	1	137	for	for	ADP
ajlm-1264	1	138	integrated	integrate	VERB
ajlm-1264	1	139	global	global	ADJ
ajlm-1264	1	140	biomedical	biomedical	ADJ
ajlm-1264	1	141	sciences	science	NOUN
ajlm-1264	1	142	,	,	PUNCT
ajlm-1264	1	143	school	school	NOUN
ajlm-1264	1	144	of	of	ADP
ajlm-1264	1	145	pharmacy	pharmacy	NOUN
ajlm-1264	1	146	and	and	CCONJ
ajlm-1264	1	147	pharmaceutical	pharmaceutical	NOUN
ajlm-1264	1	148	sciences	science	NOUN
ajlm-1264	1	149	,	,	PUNCT
ajlm-1264	1	150	university	university	NOUN
ajlm-1264	1	151	at	at	ADP
ajlm-1264	1	152	buffalo	buffalo	PROPN
ajlm-1264	1	153	,	,	PUNCT
ajlm-1264	1	154	buffalo	buffalo	PROPN
ajlm-1264	1	155	,	,	PUNCT
ajlm-1264	1	156	new	new	PROPN
ajlm-1264	1	157	york	york	PROPN
ajlm-1264	1	158	,	,	PUNCT
ajlm-1264	1	159	united	united	PROPN
ajlm-1264	1	160	states	states	PROPN
ajlm-1264	1	161	robin	robin	PROPN
ajlm-1264	1	162	difrancesco	difrancesco	PROPN
ajlm-1264	1	163	translational	translational	ADJ
ajlm-1264	1	164	pharmacology	pharmacology	NOUN
ajlm-1264	1	165	research	research	NOUN
ajlm-1264	1	166	core	core	NOUN
ajlm-1264	1	167	,	,	PUNCT
ajlm-1264	1	168	center	center	NOUN
ajlm-1264	1	169	for	for	ADP
ajlm-1264	1	170	integrated	integrate	VERB
ajlm-1264	1	171	global	global	ADJ
ajlm-1264	1	172	biomedical	biomedical	ADJ
ajlm-1264	1	173	sciences	science	NOUN
ajlm-1264	1	174	,	,	PUNCT
ajlm-1264	1	175	school	school	NOUN
ajlm-1264	1	176	of	of	ADP
ajlm-1264	1	177	pharmacy	pharmacy	NOUN
ajlm-1264	1	178	and	and	CCONJ
ajlm-1264	1	179	pharmaceutical	pharmaceutical	NOUN
ajlm-1264	1	180	sciences	science	NOUN
ajlm-1264	1	181	,	,	PUNCT
ajlm-1264	1	182	university	university	NOUN
ajlm-1264	1	183	at	at	ADP
ajlm-1264	1	184	buffalo	buffalo	PROPN
ajlm-1264	1	185	,	,	PUNCT
ajlm-1264	1	186	buffalo	buffalo	PROPN
ajlm-1264	1	187	,	,	PUNCT
ajlm-1264	1	188	new	new	PROPN
ajlm-1264	1	189	york	york	PROPN
ajlm-1264	1	190	,	,	PUNCT
ajlm-1264	1	191	united	united	PROPN
ajlm-1264	1	192	states	states	PROPN
ajlm-1264	1	193	lee	lee	PROPN
ajlm-1264	1	194	c.	c.	PROPN
ajlm-1264	1	195	winchester	winchester	PROPN
ajlm-1264	1	196	antiviral	antiviral	PROPN
ajlm-1264	1	197	pharmacology	pharmacology	NOUN
ajlm-1264	1	198	laboratory	laboratory	NOUN
ajlm-1264	1	199	,	,	PUNCT
ajlm-1264	1	200	university	university	PROPN
ajlm-1264	1	201	of	of	ADP
ajlm-1264	1	202	nebraska	nebraska	PROPN
ajlm-1264	1	203	medical	medical	ADJ
ajlm-1264	1	204	center	center	PROPN
ajlm-1264	1	205	,	,	PUNCT
ajlm-1264	1	206	omaha	omaha	PROPN
ajlm-1264	1	207	,	,	PUNCT
ajlm-1264	1	208	nebraska	nebraska	PROPN
ajlm-1264	1	209	,	,	PUNCT
ajlm-1264	1	210	united	united	PROPN
ajlm-1264	1	211	states	states	PROPN
ajlm-1264	1	212	courtney	courtney	PROPN
ajlm-1264	1	213	v.	v.	PROPN
ajlm-1264	1	214	fletcher	fletcher	PROPN
ajlm-1264	1	215	antiviral	antiviral	PROPN
ajlm-1264	1	216	pharmacology	pharmacology	PROPN
ajlm-1264	1	217	laboratory	laboratory	NOUN
ajlm-1264	1	218	,	,	PUNCT
ajlm-1264	1	219	university	university	PROPN
ajlm-1264	1	220	of	of	ADP
ajlm-1264	1	221	nebraska	nebraska	PROPN
ajlm-1264	1	222	medical	medical	ADJ
ajlm-1264	1	223	center	center	PROPN
ajlm-1264	1	224	,	,	PUNCT
ajlm-1264	1	225	omaha	omaha	PROPN
ajlm-1264	1	226	,	,	PUNCT
ajlm-1264	1	227	nebraska	nebraska	PROPN
ajlm-1264	1	228	,	,	PUNCT
ajlm-1264	1	229	united	united	PROPN
ajlm-1264	1	230	states	states	PROPN
ajlm-1264	1	231	tinashe	tinashe	PROPN
ajlm-1264	1	232	mudzviti	mudzviti	PROPN
ajlm-1264	1	233	international	international	ADJ
ajlm-1264	1	234	pharmacology	pharmacology	NOUN
ajlm-1264	1	235	specialty	specialty	NOUN
ajlm-1264	1	236	laboratory	laboratory	NOUN
ajlm-1264	1	237	,	,	PUNCT
ajlm-1264	1	238	school	school	NOUN
ajlm-1264	1	239	of	of	ADP
ajlm-1264	1	240	pharmacy	pharmacy	NOUN
ajlm-1264	1	241	,	,	PUNCT
ajlm-1264	1	242	university	university	NOUN
ajlm-1264	1	243	of	of	ADP
ajlm-1264	1	244	zimbabwe	zimbabwe	PROPN
ajlm-1264	1	245	college	college	PROPN
ajlm-1264	1	246	of	of	ADP
ajlm-1264	1	247	health	health	PROPN
ajlm-1264	1	248	sciences	sciences	PROPN
ajlm-1264	1	249	,	,	PUNCT
ajlm-1264	1	250	harare	harare	PROPN
ajlm-1264	1	251	,	,	PUNCT
ajlm-1264	1	252	zimbabwe	zimbabwe	PROPN
ajlm-1264	1	253	charles	charles	PROPN
ajlm-1264	1	254	c.	c.	PROPN
ajlm-1264	1	255	maponga	maponga	PROPN
ajlm-1264	1	256	international	international	PROPN
ajlm-1264	1	257	pharmacology	pharmacology	NOUN
ajlm-1264	1	258	specialty	specialty	NOUN
ajlm-1264	1	259	laboratory	laboratory	NOUN
ajlm-1264	1	260	,	,	PUNCT
ajlm-1264	1	261	school	school	NOUN
ajlm-1264	1	262	of	of	ADP
ajlm-1264	1	263	pharmacy	pharmacy	NOUN
ajlm-1264	1	264	,	,	PUNCT
ajlm-1264	1	265	university	university	NOUN
ajlm-1264	1	266	of	of	ADP
ajlm-1264	1	267	zimbabwe	zimbabwe	PROPN
ajlm-1264	1	268	college	college	PROPN
ajlm-1264	1	269	of	of	ADP
ajlm-1264	1	270	health	health	PROPN
ajlm-1264	1	271	sciences	sciences	PROPN
ajlm-1264	1	272	,	,	PUNCT
ajlm-1264	1	273	harare	harare	PROPN
ajlm-1264	1	274	,	,	PUNCT
ajlm-1264	1	275	zimbabwe	zimbabwe	PROPN
ajlm-1264	1	276	translational	translational	ADJ
ajlm-1264	1	277	pharmacology	pharmacology	NOUN
ajlm-1264	1	278	research	research	NOUN
ajlm-1264	1	279	core	core	NOUN
ajlm-1264	1	280	,	,	PUNCT
ajlm-1264	1	281	center	center	NOUN
ajlm-1264	1	282	for	for	ADP
ajlm-1264	1	283	integrated	integrate	VERB
ajlm-1264	1	284	global	global	ADJ
ajlm-1264	1	285	biomedical	biomedical	ADJ
ajlm-1264	1	286	sciences	science	NOUN
ajlm-1264	1	287	,	,	PUNCT
ajlm-1264	1	288	school	school	NOUN
ajlm-1264	1	289	of	of	ADP
ajlm-1264	1	290	pharmacy	pharmacy	NOUN
ajlm-1264	1	291	and	and	CCONJ
ajlm-1264	1	292	pharmaceutical	pharmaceutical	NOUN
ajlm-1264	1	293	sciences	science	NOUN
ajlm-1264	1	294	,	,	PUNCT
ajlm-1264	1	295	university	university	NOUN
ajlm-1264	1	296	at	at	ADP
ajlm-1264	1	297	buffalo	buffalo	PROPN
ajlm-1264	1	298	,	,	PUNCT
ajlm-1264	1	299	buffalo	buffalo	PROPN
ajlm-1264	1	300	,	,	PUNCT
ajlm-1264	1	301	new	new	PROPN
ajlm-1264	1	302	york	york	PROPN
ajlm-1264	1	303	,	,	PUNCT
ajlm-1264	1	304	united	united	PROPN
ajlm-1264	1	305	states	states	PROPN
ajlm-1264	1	306	gene	gene	PROPN
ajlm-1264	1	307	d.	d.	PROPN
ajlm-1264	1	308	morse	morse	PROPN
ajlm-1264	1	309	translational	translational	PROPN
ajlm-1264	1	310	pharmacology	pharmacology	NOUN
ajlm-1264	1	311	research	research	NOUN
ajlm-1264	1	312	core	core	NOUN
ajlm-1264	1	313	,	,	PUNCT
ajlm-1264	1	314	center	center	NOUN
ajlm-1264	1	315	for	for	ADP
ajlm-1264	1	316	integrated	integrate	VERB
ajlm-1264	1	317	global	global	ADJ
ajlm-1264	1	318	biomedical	biomedical	ADJ
ajlm-1264	1	319	sciences	science	NOUN
ajlm-1264	1	320	,	,	PUNCT
ajlm-1264	1	321	school	school	NOUN
ajlm-1264	1	322	of	of	ADP
ajlm-1264	1	323	pharmacy	pharmacy	NOUN
ajlm-1264	1	324	and	and	CCONJ
ajlm-1264	1	325	pharmaceutical	pharmaceutical	NOUN
ajlm-1264	1	326	sciences	science	NOUN
ajlm-1264	1	327	,	,	PUNCT
ajlm-1264	1	328	university	university	NOUN
ajlm-1264	1	329	at	at	ADP
ajlm-1264	1	330	buffalo	buffalo	PROPN
ajlm-1264	1	331	,	,	PUNCT
ajlm-1264	1	332	buffalo	buffalo	PROPN
ajlm-1264	1	333	,	,	PUNCT
ajlm-1264	1	334	new	new	PROPN
ajlm-1264	1	335	york	york	PROPN
ajlm-1264	1	336	,	,	PUNCT
ajlm-1264	1	337	united	united	PROPN
ajlm-1264	1	338	states	states	PROPN
ajlm-1264	1	339	citation	citation	PROPN
ajlm-1264	1	340	makita	makita	PROPN
ajlm-1264	1	341	-	-	PUNCT
ajlm-1264	1	342	chingombe	chingombe	PROPN
ajlm-1264	2	1	f	f	NOUN
ajlm-1264	2	2	,	,	PUNCT
ajlm-1264	2	3	podany	podany	NOUN
ajlm-1264	2	4	at	at	ADP
ajlm-1264	2	5	,	,	PUNCT
ajlm-1264	2	6	mykris	mykris	PROPN
ajlm-1264	2	7	t	t	PROPN
ajlm-1264	2	8	,	,	PUNCT
ajlm-1264	2	9	et	et	PROPN
ajlm-1264	2	10	al	al	PROPN
ajlm-1264	2	11	.	.	PUNCT
ajlm-1264	3	1	cross	cross	NOUN
ajlm-1264	3	2	-	-	NOUN
ajlm-1264	3	3	validation	validation	NOUN
ajlm-1264	3	4	of	of	ADP
ajlm-1264	3	5	a	a	DET
ajlm-1264	3	6	high	high	ADJ
ajlm-1264	3	7	-	-	PUNCT
ajlm-1264	3	8	performance	performance	NOUN
ajlm-1264	3	9	liquid	liquid	NOUN
ajlm-1264	3	10	chromatography	chromatography	NOUN
ajlm-1264	3	11	nevirapine	nevirapine	ADJ
ajlm-1264	3	12	plasma	plasma	NOUN
ajlm-1264	3	13	assay	assay	VERB
ajlm-1264	3	14	in	in	ADP
ajlm-1264	3	15	a	a	DET
ajlm-1264	3	16	resource	resource	NOUN
ajlm-1264	3	17	-	-	PUNCT
ajlm-1264	3	18	limited	limit	VERB
ajlm-1264	3	19	setting	setting	NOUN
ajlm-1264	3	20	in	in	ADP
ajlm-1264	3	21	zimbabwe	zimbabwe	PROPN
ajlm-1264	3	22	.	.	PUNCT
ajlm-1264	4	1	afr	afr	PROPN
ajlm-1264	4	2	j	j	PROPN
ajlm-1264	4	3	lab	lab	PROPN
ajlm-1264	4	4	med	med	PROPN
ajlm-1264	4	5	.	.	PUNCT
ajlm-1264	5	1	2021;10(1	2021;10(1	NUM
ajlm-1264	5	2	)	)	PUNCT
ajlm-1264	5	3	,	,	PUNCT
ajlm-1264	5	4	a1264	a1264	NOUN
ajlm-1264	5	5	.	.	PUNCT
ajlm-1264	6	1	https://doi.org/10.4102/ajlm.v10i1.1264	https://doi.org/10.4102/ajlm.v10i1.1264	PUNCT
ajlm-1264	6	2	brief	brief	ADJ
ajlm-1264	6	3	report	report	NOUN
ajlm-1264	6	4	cross	cross	NOUN
ajlm-1264	6	5	-	-	NOUN
ajlm-1264	6	6	validation	validation	NOUN
ajlm-1264	6	7	of	of	ADP
ajlm-1264	6	8	a	a	DET
ajlm-1264	6	9	high	high	ADJ
ajlm-1264	6	10	-	-	PUNCT
ajlm-1264	6	11	performance	performance	NOUN
ajlm-1264	6	12	liquid	liquid	NOUN
ajlm-1264	6	13	chromatography	chromatography	NOUN
ajlm-1264	6	14	nevirapine	nevirapine	ADJ
ajlm-1264	6	15	plasma	plasma	NOUN
ajlm-1264	6	16	assay	assay	VERB
ajlm-1264	6	17	in	in	ADP
ajlm-1264	6	18	a	a	DET
ajlm-1264	6	19	resource	resource	NOUN
ajlm-1264	6	20	-	-	PUNCT
ajlm-1264	6	21	limited	limit	VERB
ajlm-1264	6	22	setting	setting	NOUN
ajlm-1264	6	23	in	in	ADP
ajlm-1264	6	24	zimbabwe	zimbabwe	PROPN
ajlm-1264	6	25	faithful	faithful	PROPN
ajlm-1264	6	26	makita	makita	PROPN
ajlm-1264	6	27	-	-	PUNCT
ajlm-1264	6	28	chingombe	chingombe	NOUN
ajlm-1264	6	29	,	,	PUNCT
ajlm-1264	6	30	anthony	anthony	PROPN
ajlm-1264	6	31	t.	t.	PROPN
ajlm-1264	6	32	podany	podany	NOUN
ajlm-1264	6	33	,	,	PUNCT
ajlm-1264	6	34	timothy	timothy	PROPN
ajlm-1264	6	35	mykris	mykris	NOUN
ajlm-1264	6	36	,	,	PUNCT
ajlm-1264	6	37	farai	farai	NUM
ajlm-1264	6	38	muzambi	muzambi	PROPN
ajlm-1264	6	39	,	,	PUNCT
ajlm-1264	6	40	richard	richard	PROPN
ajlm-1264	6	41	w.	w.	PROPN
ajlm-1264	6	42	browne	browne	PROPN
ajlm-1264	6	43	,	,	PUNCT
ajlm-1264	6	44	andrew	andrew	PROPN
ajlm-1264	6	45	j.	j.	PROPN
ajlm-1264	6	46	ocque	ocque	PROPN
ajlm-1264	6	47	,	,	PUNCT
ajlm-1264	6	48	robin	robin	PROPN
ajlm-1264	6	49	difrancesco	difrancesco	PROPN
ajlm-1264	6	50	,	,	PUNCT
ajlm-1264	6	51	lee	lee	PROPN
ajlm-1264	6	52	c.	c.	PROPN
ajlm-1264	6	53	winchester	winchester	PROPN
ajlm-1264	6	54	,	,	PUNCT
ajlm-1264	6	55	courtney	courtney	PROPN
ajlm-1264	6	56	v.	v.	PROPN
ajlm-1264	6	57	fletcher	fletcher	PROPN
ajlm-1264	6	58	,	,	PUNCT
ajlm-1264	6	59	tinashe	tinashe	PROPN
ajlm-1264	6	60	mudzviti	mudzviti	PROPN
ajlm-1264	6	61	,	,	PUNCT
ajlm-1264	6	62	charles	charles	PROPN
ajlm-1264	6	63	c.	c.	PROPN
ajlm-1264	6	64	maponga	maponga	PROPN
ajlm-1264	6	65	,	,	PUNCT
ajlm-1264	6	66	gene	gene	PROPN
ajlm-1264	6	67	d.	d.	PROPN
ajlm-1264	6	68	morse	morse	PROPN
ajlm-1264	6	69	received	receive	VERB
ajlm-1264	6	70	:	:	PUNCT
ajlm-1264	6	71	08	08	NUM
ajlm-1264	6	72	may	may	PROPN
ajlm-1264	6	73	2020	2020	NUM
ajlm-1264	6	74	;	;	PUNCT
ajlm-1264	6	75	accepted	accept	VERB
ajlm-1264	6	76	:	:	PUNCT
ajlm-1264	6	77	24	24	NUM
ajlm-1264	6	78	feb	feb	NOUN
ajlm-1264	6	79	.	.	PROPN
ajlm-1264	6	80	2021	2021	NUM
ajlm-1264	6	81	;	;	PUNCT
ajlm-1264	6	82	published	publish	VERB
ajlm-1264	6	83	:	:	PUNCT
ajlm-1264	6	84	08	08	NUM
ajlm-1264	6	85	july	july	PROPN
ajlm-1264	6	86	2021	2021	NUM
ajlm-1264	6	87	copyright	copyright	NOUN
ajlm-1264	6	88	:	:	PUNCT
ajlm-1264	6	89	©	©	PROPN
ajlm-1264	6	90	2021	2021	NUM
ajlm-1264	6	91	.	.	PUNCT
ajlm-1264	7	1	the	the	DET
ajlm-1264	7	2	author(s	author(s	PROPN
ajlm-1264	7	3	)	)	PUNCT
ajlm-1264	7	4	.	.	PUNCT
ajlm-1264	8	1	licensee	licensee	NOUN
ajlm-1264	8	2	:	:	PUNCT
ajlm-1264	8	3	aosis	aosis	NOUN
ajlm-1264	8	4	.	.	PUNCT
ajlm-1264	9	1	this	this	PRON
ajlm-1264	9	2	is	be	AUX
ajlm-1264	9	3	an	an	DET
ajlm-1264	9	4	open	open	ADJ
ajlm-1264	9	5	access	access	NOUN
ajlm-1264	9	6	article	article	NOUN
ajlm-1264	9	7	distributed	distribute	VERB
ajlm-1264	9	8	under	under	ADP
ajlm-1264	9	9	the	the	DET
ajlm-1264	9	10	terms	term	NOUN
ajlm-1264	9	11	of	of	ADP
ajlm-1264	9	12	the	the	DET
ajlm-1264	9	13	creative	creative	ADJ
ajlm-1264	9	14	commons	common	NOUN
ajlm-1264	9	15	attribution	attribution	NOUN
ajlm-1264	9	16	license	license	NOUN
ajlm-1264	9	17	,	,	PUNCT
ajlm-1264	9	18	which	which	PRON
ajlm-1264	9	19	permits	permit	VERB
ajlm-1264	9	20	unrestricted	unrestricted	ADJ
ajlm-1264	9	21	use	use	NOUN
ajlm-1264	9	22	,	,	PUNCT
ajlm-1264	9	23	distribution	distribution	NOUN
ajlm-1264	9	24	,	,	PUNCT
ajlm-1264	9	25	and	and	CCONJ
ajlm-1264	9	26	reproduction	reproduction	NOUN
ajlm-1264	9	27	in	in	ADP
ajlm-1264	9	28	any	any	DET
ajlm-1264	9	29	medium	medium	NOUN
ajlm-1264	9	30	,	,	PUNCT
ajlm-1264	9	31	provided	provide	VERB
ajlm-1264	9	32	the	the	DET
ajlm-1264	9	33	original	original	ADJ
ajlm-1264	9	34	work	work	NOUN
ajlm-1264	9	35	is	be	AUX
ajlm-1264	9	36	properly	properly	ADV
ajlm-1264	9	37	cited	cite	VERB
ajlm-1264	9	38	.	.	PUNCT
ajlm-1264	10	1	abstract	abstract	ADJ
ajlm-1264	10	2	an	an	DET
ajlm-1264	10	3	international	international	ADJ
ajlm-1264	10	4	hiv	hiv	PROPN
ajlm-1264	10	5	pharmacology	pharmacology	NOUN
ajlm-1264	10	6	specialty	specialty	NOUN
ajlm-1264	10	7	laboratory	laboratory	NOUN
ajlm-1264	10	8	(	(	PUNCT
ajlm-1264	10	9	psl	psl	PROPN
ajlm-1264	10	10	)	)	PUNCT
ajlm-1264	10	11	was	be	AUX
ajlm-1264	10	12	established	establish	VERB
ajlm-1264	10	13	at	at	ADP
ajlm-1264	10	14	the	the	DET
ajlm-1264	10	15	university	university	NOUN
ajlm-1264	10	16	of	of	ADP
ajlm-1264	10	17	zimbabwe	zimbabwe	PROPN
ajlm-1264	10	18	to	to	PART
ajlm-1264	10	19	increase	increase	VERB
ajlm-1264	10	20	bioanalytical	bioanalytical	ADJ
ajlm-1264	10	21	and	and	CCONJ
ajlm-1264	10	22	investigator	investigator	NOUN
ajlm-1264	10	23	capacities	capacity	NOUN
ajlm-1264	10	24	.	.	PUNCT
ajlm-1264	11	1	quantitation	quantitation	NOUN
ajlm-1264	11	2	of	of	ADP
ajlm-1264	11	3	plasma	plasma	NOUN
ajlm-1264	11	4	nevirapine	nevirapine	ADJ
ajlm-1264	11	5	in	in	ADP
ajlm-1264	11	6	samples	sample	NOUN
ajlm-1264	11	7	from	from	ADP
ajlm-1264	11	8	the	the	DET
ajlm-1264	11	9	aids	aids	PROPN
ajlm-1264	11	10	clinical	clinical	ADJ
ajlm-1264	11	11	trials	trial	NOUN
ajlm-1264	11	12	group	group	NOUN
ajlm-1264	11	13	protocol	protocol	NOUN
ajlm-1264	11	14	5279	5279	NUM
ajlm-1264	11	15	was	be	AUX
ajlm-1264	11	16	compared	compare	VERB
ajlm-1264	11	17	between	between	ADP
ajlm-1264	11	18	the	the	DET
ajlm-1264	11	19	university	university	PROPN
ajlm-1264	11	20	of	of	ADP
ajlm-1264	11	21	nebraska	nebraska	PROPN
ajlm-1264	11	22	medical	medical	PROPN
ajlm-1264	11	23	center	center	PROPN
ajlm-1264	11	24	psl	psl	PROPN
ajlm-1264	11	25	and	and	CCONJ
ajlm-1264	11	26	the	the	DET
ajlm-1264	11	27	university	university	NOUN
ajlm-1264	11	28	of	of	ADP
ajlm-1264	11	29	zimbabwe	zimbabwe	PROPN
ajlm-1264	11	30	psl	psl	PROPN
ajlm-1264	11	31	.	.	PUNCT
ajlm-1264	12	1	both	both	DET
ajlm-1264	12	2	psls	psls	NOUN
ajlm-1264	12	3	employed	employ	VERB
ajlm-1264	12	4	internally	internally	ADV
ajlm-1264	12	5	developed	develop	VERB
ajlm-1264	12	6	methods	method	NOUN
ajlm-1264	12	7	utilising	utilise	VERB
ajlm-1264	12	8	reverse	reverse	NOUN
ajlm-1264	12	9	-	-	PUNCT
ajlm-1264	12	10	phase	phase	NOUN
ajlm-1264	12	11	high	high	ADJ
ajlm-1264	12	12	-	-	PUNCT
ajlm-1264	12	13	performance	performance	NOUN
ajlm-1264	12	14	liquid	liquid	ADJ
ajlm-1264	12	15	chromatography	chromatography	NOUN
ajlm-1264	12	16	with	with	ADP
ajlm-1264	12	17	ultraviolet	ultraviolet	ADJ
ajlm-1264	12	18	detection	detection	NOUN
ajlm-1264	12	19	.	.	PUNCT
ajlm-1264	13	1	eighty	eighty	NUM
ajlm-1264	13	2	-	-	PUNCT
ajlm-1264	13	3	seven	seven	NUM
ajlm-1264	13	4	percent	percent	NOUN
ajlm-1264	13	5	of	of	ADP
ajlm-1264	13	6	the	the	DET
ajlm-1264	13	7	cross	cross	ADJ
ajlm-1264	13	8	-	-	ADJ
ajlm-1264	13	9	validation	validation	ADJ
ajlm-1264	13	10	results	result	NOUN
ajlm-1264	13	11	exhibited	exhibit	VERB
ajlm-1264	13	12	±	±	NUM
ajlm-1264	13	13	20	20	NUM
ajlm-1264	13	14	%	%	NOUN
ajlm-1264	13	15	difference	difference	NOUN
ajlm-1264	13	16	.	.	PUNCT
ajlm-1264	14	1	keywords	keyword	NOUN
ajlm-1264	14	2	:	:	PUNCT
ajlm-1264	14	3	cross	cross	NOUN
ajlm-1264	14	4	-	-	NOUN
ajlm-1264	14	5	validation	validation	ADJ
ajlm-1264	14	6	;	;	PUNCT
ajlm-1264	14	7	hiv	hiv	PROPN
ajlm-1264	14	8	;	;	PUNCT
ajlm-1264	14	9	root	root	NOUN
ajlm-1264	14	10	-	-	PUNCT
ajlm-1264	14	11	cause	cause	NOUN
ajlm-1264	14	12	analysis	analysis	NOUN
ajlm-1264	14	13	;	;	PUNCT
ajlm-1264	14	14	high	high	ADJ
ajlm-1264	14	15	-	-	PUNCT
ajlm-1264	14	16	performance	performance	NOUN
ajlm-1264	14	17	liquid	liquid	ADJ
ajlm-1264	14	18	chromatography	chromatography	NOUN
ajlm-1264	14	19	.	.	PUNCT
ajlm-1264	15	1	introduction	introduction	NOUN
ajlm-1264	15	2	the	the	DET
ajlm-1264	15	3	university	university	NOUN
ajlm-1264	15	4	of	of	ADP
ajlm-1264	15	5	zimbabwe	zimbabwe	X
ajlm-1264	15	6	(	(	PUNCT
ajlm-1264	15	7	uz	uz	PROPN
ajlm-1264	15	8	)	)	PUNCT
ajlm-1264	15	9	international	international	PROPN
ajlm-1264	15	10	hiv	hiv	PROPN
ajlm-1264	15	11	pharmacology	pharmacology	NOUN
ajlm-1264	15	12	speciality	speciality	PROPN
ajlm-1264	15	13	laboratory	laboratory	NOUN
ajlm-1264	15	14	(	(	PUNCT
ajlm-1264	15	15	ipsl	ipsl	PROPN
ajlm-1264	15	16	)	)	PUNCT
ajlm-1264	15	17	was	be	AUX
ajlm-1264	15	18	established	establish	VERB
ajlm-1264	15	19	to	to	PART
ajlm-1264	15	20	increase	increase	VERB
ajlm-1264	15	21	hiv	hiv	PROPN
ajlm-1264	15	22	pharmacology	pharmacology	NOUN
ajlm-1264	15	23	-	-	PUNCT
ajlm-1264	15	24	related	relate	VERB
ajlm-1264	15	25	research	research	NOUN
ajlm-1264	15	26	and	and	CCONJ
ajlm-1264	15	27	support	support	NOUN
ajlm-1264	15	28	research	research	NOUN
ajlm-1264	15	29	investigator	investigator	NOUN
ajlm-1264	15	30	capacity	capacity	NOUN
ajlm-1264	15	31	in	in	ADP
ajlm-1264	15	32	africa.1	africa.1	PROPN
ajlm-1264	15	33	the	the	DET
ajlm-1264	15	34	uz	uz	NOUN
ajlm-1264	15	35	-	-	PUNCT
ajlm-1264	15	36	ipsl	ipsl	PROPN
ajlm-1264	15	37	performs	perform	VERB
ajlm-1264	15	38	drug	drug	NOUN
ajlm-1264	15	39	development	development	NOUN
ajlm-1264	15	40	assay	assay	PROPN
ajlm-1264	15	41	and	and	CCONJ
ajlm-1264	15	42	clinical	clinical	ADJ
ajlm-1264	15	43	research	research	NOUN
ajlm-1264	15	44	specimens	specimen	NOUN
ajlm-1264	15	45	analyses	analysis	NOUN
ajlm-1264	15	46	,	,	PUNCT
ajlm-1264	15	47	specifically	specifically	ADV
ajlm-1264	15	48	drug	drug	NOUN
ajlm-1264	15	49	-	-	PUNCT
ajlm-1264	15	50	drug	drug	NOUN
ajlm-1264	15	51	interactions	interaction	NOUN
ajlm-1264	15	52	,	,	PUNCT
ajlm-1264	15	53	pharmacokinetic	pharmacokinetic	ADJ
ajlm-1264	15	54	and	and	CCONJ
ajlm-1264	15	55	pharmacodynamic	pharmacodynamic	ADJ
ajlm-1264	15	56	data	datum	NOUN
ajlm-1264	15	57	analyses	analysis	NOUN
ajlm-1264	15	58	.	.	PUNCT
ajlm-1264	16	1	the	the	DET
ajlm-1264	16	2	clinical	clinical	ADJ
ajlm-1264	16	3	pharmacology	pharmacology	NOUN
ajlm-1264	16	4	quality	quality	NOUN
ajlm-1264	16	5	assurance	assurance	NOUN
ajlm-1264	16	6	programme	programme	NOUN
ajlm-1264	16	7	,	,	PUNCT
ajlm-1264	16	8	which	which	PRON
ajlm-1264	16	9	monitors	monitor	VERB
ajlm-1264	16	10	all	all	DET
ajlm-1264	16	11	psls	psls	NOUN
ajlm-1264	16	12	within	within	ADP
ajlm-1264	16	13	the	the	DET
ajlm-1264	16	14	aids	aids	PROPN
ajlm-1264	16	15	clinical	clinical	ADJ
ajlm-1264	16	16	trials	trial	NOUN
ajlm-1264	16	17	group	group	NOUN
ajlm-1264	16	18	,	,	PUNCT
ajlm-1264	16	19	provided	provide	VERB
ajlm-1264	16	20	technical	technical	ADJ
ajlm-1264	16	21	guidance	guidance	NOUN
ajlm-1264	16	22	to	to	ADP
ajlm-1264	16	23	and	and	CCONJ
ajlm-1264	16	24	developed	develop	VERB
ajlm-1264	16	25	a	a	DET
ajlm-1264	16	26	comparative	comparative	ADJ
ajlm-1264	16	27	nevirapine	nevirapine	ADJ
ajlm-1264	16	28	validation	validation	NOUN
ajlm-1264	16	29	study	study	NOUN
ajlm-1264	16	30	for	for	ADP
ajlm-1264	16	31	the	the	DET
ajlm-1264	16	32	uz	uz	NOUN
ajlm-1264	16	33	-	-	PUNCT
ajlm-1264	16	34	ipsl	ipsl	NOUN
ajlm-1264	16	35	to	to	PART
ajlm-1264	16	36	analyse	analyse	AUX
ajlm-1264	16	37	replicate	replicate	VERB
ajlm-1264	16	38	hiv	hiv	PROPN
ajlm-1264	16	39	clinical	clinical	ADJ
ajlm-1264	16	40	samples	sample	NOUN
ajlm-1264	16	41	.	.	PUNCT
ajlm-1264	17	1	validation	validation	NOUN
ajlm-1264	17	2	of	of	ADP
ajlm-1264	17	3	the	the	DET
ajlm-1264	17	4	nevirapine	nevirapine	ADJ
ajlm-1264	17	5	bioanalytics	bioanalytic	NOUN
ajlm-1264	17	6	method2	method2	PROPN
ajlm-1264	17	7	was	be	AUX
ajlm-1264	17	8	essential	essential	ADJ
ajlm-1264	17	9	at	at	ADP
ajlm-1264	17	10	the	the	DET
ajlm-1264	17	11	time	time	NOUN
ajlm-1264	17	12	because	because	SCONJ
ajlm-1264	17	13	of	of	ADP
ajlm-1264	17	14	nevirapine	nevirapine	ADJ
ajlm-1264	17	15	use	use	NOUN
ajlm-1264	17	16	in	in	ADP
ajlm-1264	17	17	the	the	DET
ajlm-1264	17	18	sub	sub	ADJ
ajlm-1264	17	19	-	-	ADJ
ajlm-1264	17	20	saharan	saharan	ADJ
ajlm-1264	17	21	region	region	NOUN
ajlm-1264	17	22	and	and	CCONJ
ajlm-1264	17	23	results	result	NOUN
ajlm-1264	17	24	were	be	AUX
ajlm-1264	17	25	generated	generate	VERB
ajlm-1264	17	26	by	by	ADP
ajlm-1264	17	27	a	a	DET
ajlm-1264	17	28	reverse	reverse	NOUN
ajlm-1264	17	29	-	-	PUNCT
ajlm-1264	17	30	phase	phase	NOUN
ajlm-1264	17	31	high	high	ADJ
ajlm-1264	17	32	-	-	PUNCT
ajlm-1264	17	33	performance	performance	NOUN
ajlm-1264	17	34	liquid	liquid	ADJ
ajlm-1264	17	35	chromatography	chromatography	NOUN
ajlm-1264	17	36	(	(	PUNCT
ajlm-1264	17	37	hplc	hplc	NOUN
ajlm-1264	17	38	)	)	PUNCT
ajlm-1264	17	39	system	system	NOUN
ajlm-1264	17	40	using	use	VERB
ajlm-1264	17	41	ultraviolet	ultraviolet	ADJ
ajlm-1264	17	42	detection	detection	NOUN
ajlm-1264	17	43	with	with	ADP
ajlm-1264	17	44	gradient	gradient	NOUN
ajlm-1264	17	45	-	-	PUNCT
ajlm-1264	17	46	elution	elution	NOUN
ajlm-1264	17	47	separation.3,4,5	separation.3,4,5	NOUN
ajlm-1264	17	48	this	this	DET
ajlm-1264	17	49	report	report	NOUN
ajlm-1264	17	50	compares	compare	VERB
ajlm-1264	17	51	nevirapine	nevirapine	ADJ
ajlm-1264	17	52	bioanalysis	bioanalysis	NOUN
ajlm-1264	17	53	at	at	ADP
ajlm-1264	17	54	two	two	NUM
ajlm-1264	17	55	laboratories	laboratory	NOUN
ajlm-1264	17	56	:	:	PUNCT
ajlm-1264	17	57	the	the	DET
ajlm-1264	17	58	united	united	PROPN
ajlm-1264	17	59	states	states	PROPN
ajlm-1264	17	60	-	-	PUNCT
ajlm-1264	17	61	based	base	VERB
ajlm-1264	17	62	,	,	PUNCT
ajlm-1264	17	63	university	university	PROPN
ajlm-1264	17	64	of	of	ADP
ajlm-1264	17	65	nebraska	nebraska	PROPN
ajlm-1264	17	66	medical	medical	PROPN
ajlm-1264	17	67	center	center	PROPN
ajlm-1264	17	68	pharmacology	pharmacology	NOUN
ajlm-1264	17	69	specialty	specialty	NOUN
ajlm-1264	17	70	laboratory	laboratory	NOUN
ajlm-1264	17	71	(	(	PUNCT
ajlm-1264	17	72	unmc	unmc	NOUN
ajlm-1264	17	73	-	-	PUNCT
ajlm-1264	17	74	psl	psl	NOUN
ajlm-1264	17	75	)	)	PUNCT
ajlm-1264	17	76	and	and	CCONJ
ajlm-1264	17	77	the	the	DET
ajlm-1264	17	78	uz	uz	NOUN
ajlm-1264	17	79	-	-	PUNCT
ajlm-1264	17	80	ipsl	ipsl	NOUN
ajlm-1264	17	81	.	.	PUNCT
ajlm-1264	18	1	the	the	DET
ajlm-1264	18	2	unmc	unmc	PROPN
ajlm-1264	18	3	-	-	PUNCT
ajlm-1264	18	4	psl	psl	NOUN
ajlm-1264	18	5	served	serve	VERB
ajlm-1264	18	6	as	as	SCONJ
ajlm-1264	18	7	the	the	DET
ajlm-1264	18	8	aids	aids	PROPN
ajlm-1264	18	9	clinical	clinical	ADJ
ajlm-1264	18	10	trials	trial	NOUN
ajlm-1264	18	11	group	group	NOUN
ajlm-1264	18	12	5279	5279	NUM
ajlm-1264	18	13	(	(	PUNCT
ajlm-1264	18	14	a5279	a5279	NOUN
ajlm-1264	18	15	)	)	PUNCT
ajlm-1264	18	16	protocol	protocol	NOUN
ajlm-1264	18	17	designated	designate	VERB
ajlm-1264	18	18	laboratory	laboratory	NOUN
ajlm-1264	18	19	.	.	PUNCT
ajlm-1264	19	1	the	the	DET
ajlm-1264	19	2	unmc	unmc	NOUN
ajlm-1264	19	3	-	-	PUNCT
ajlm-1264	19	4	psl	psl	NOUN
ajlm-1264	19	5	,	,	PUNCT
ajlm-1264	19	6	during	during	ADP
ajlm-1264	19	7	the	the	DET
ajlm-1264	19	8	time	time	NOUN
ajlm-1264	19	9	of	of	ADP
ajlm-1264	19	10	the	the	DET
ajlm-1264	19	11	a5279	a5279	PROPN
ajlm-1264	19	12	study	study	NOUN
ajlm-1264	19	13	,	,	PUNCT
ajlm-1264	19	14	participated	participate	VERB
ajlm-1264	19	15	in	in	ADP
ajlm-1264	19	16	the	the	DET
ajlm-1264	19	17	clinical	clinical	ADJ
ajlm-1264	19	18	pharmacology	pharmacology	NOUN
ajlm-1264	19	19	quality	quality	NOUN
ajlm-1264	19	20	assurance	assurance	NOUN
ajlm-1264	19	21	proficiency	proficiency	NOUN
ajlm-1264	19	22	testing	testing	NOUN
ajlm-1264	19	23	(	(	PUNCT
ajlm-1264	19	24	pt	pt	NOUN
ajlm-1264	19	25	)	)	PUNCT
ajlm-1264	19	26	programme	programme	NOUN
ajlm-1264	19	27	to	to	PART
ajlm-1264	19	28	assure	assure	VERB
ajlm-1264	19	29	nevirapine	nevirapine	ADJ
ajlm-1264	19	30	assay	assay	NOUN
ajlm-1264	19	31	performance	performance	NOUN
ajlm-1264	19	32	and	and	CCONJ
ajlm-1264	19	33	accuracy	accuracy	NOUN
ajlm-1264	19	34	.	.	PUNCT
ajlm-1264	20	1	although	although	SCONJ
ajlm-1264	20	2	each	each	DET
ajlm-1264	20	3	psl	psl	NOUN
ajlm-1264	20	4	validated	validate	VERB
ajlm-1264	20	5	the	the	DET
ajlm-1264	20	6	nevirapine	nevirapine	ADJ
ajlm-1264	20	7	assay	assay	NOUN
ajlm-1264	20	8	separately	separately	ADV
ajlm-1264	20	9	,	,	PUNCT
ajlm-1264	20	10	the	the	DET
ajlm-1264	20	11	lack	lack	NOUN
ajlm-1264	20	12	of	of	ADP
ajlm-1264	20	13	data	datum	NOUN
ajlm-1264	20	14	comparing	compare	VERB
ajlm-1264	20	15	the	the	DET
ajlm-1264	20	16	bioanalytical	bioanalytical	ADJ
ajlm-1264	20	17	capacity	capacity	NOUN
ajlm-1264	20	18	of	of	ADP
ajlm-1264	20	19	pharmacology	pharmacology	NOUN
ajlm-1264	20	20	laboratories	laboratory	NOUN
ajlm-1264	20	21	in	in	ADP
ajlm-1264	20	22	low	low	ADJ
ajlm-1264	20	23	-	-	PUNCT
ajlm-1264	20	24	middle	middle	ADJ
ajlm-1264	20	25	income	income	NOUN
ajlm-1264	20	26	countries	country	NOUN
ajlm-1264	20	27	using	use	VERB
ajlm-1264	20	28	clinical	clinical	ADJ
ajlm-1264	20	29	samples	sample	NOUN
ajlm-1264	20	30	(	(	PUNCT
ajlm-1264	20	31	rather	rather	ADV
ajlm-1264	20	32	than	than	ADP
ajlm-1264	20	33	spiked	spiked	ADJ
ajlm-1264	20	34	plasma	plasma	NOUN
ajlm-1264	20	35	samples	sample	NOUN
ajlm-1264	20	36	)	)	PUNCT
ajlm-1264	20	37	was	be	AUX
ajlm-1264	20	38	the	the	DET
ajlm-1264	20	39	justification	justification	NOUN
ajlm-1264	20	40	for	for	ADP
ajlm-1264	20	41	this	this	DET
ajlm-1264	20	42	project	project	NOUN
ajlm-1264	20	43	.	.	PUNCT
ajlm-1264	21	1	therefore	therefore	ADV
ajlm-1264	21	2	,	,	PUNCT
ajlm-1264	21	3	implementation	implementation	NOUN
ajlm-1264	21	4	of	of	ADP
ajlm-1264	21	5	the	the	DET
ajlm-1264	21	6	project	project	NOUN
ajlm-1264	21	7	was	be	AUX
ajlm-1264	21	8	the	the	DET
ajlm-1264	21	9	last	last	ADJ
ajlm-1264	21	10	stage	stage	NOUN
ajlm-1264	21	11	in	in	ADP
ajlm-1264	21	12	determining	determine	VERB
ajlm-1264	21	13	uz	uz	NOUN
ajlm-1264	21	14	-	-	PUNCT
ajlm-1264	21	15	ipsl	ipsl	PROPN
ajlm-1264	21	16	’s	’s	PART
ajlm-1264	21	17	readiness	readiness	NOUN
ajlm-1264	21	18	to	to	PART
ajlm-1264	21	19	begin	begin	VERB
ajlm-1264	21	20	assaying	assay	VERB
ajlm-1264	21	21	human	human	ADJ
ajlm-1264	21	22	samples	sample	NOUN
ajlm-1264	21	23	for	for	ADP
ajlm-1264	21	24	clinical	clinical	ADJ
ajlm-1264	21	25	trials	trial	NOUN
ajlm-1264	21	26	.	.	PUNCT
ajlm-1264	22	1	methods	method	NOUN
ajlm-1264	22	2	ethical	ethical	ADJ
ajlm-1264	22	3	considerations	consideration	NOUN
ajlm-1264	22	4	data	datum	NOUN
ajlm-1264	22	5	files	file	NOUN
ajlm-1264	22	6	used	use	VERB
ajlm-1264	22	7	in	in	ADP
ajlm-1264	22	8	this	this	DET
ajlm-1264	22	9	comparison	comparison	NOUN
ajlm-1264	22	10	study	study	NOUN
ajlm-1264	22	11	were	be	AUX
ajlm-1264	22	12	de	de	ADJ
ajlm-1264	22	13	-	-	VERB
ajlm-1264	22	14	identified	identify	VERB
ajlm-1264	22	15	and	and	CCONJ
ajlm-1264	22	16	clinical	clinical	ADJ
ajlm-1264	22	17	pharmacology	pharmacology	NOUN
ajlm-1264	22	18	quality	quality	NOUN
ajlm-1264	22	19	assurance	assurance	NOUN
ajlm-1264	22	20	was	be	AUX
ajlm-1264	22	21	blinded	blind	VERB
ajlm-1264	22	22	to	to	ADP
ajlm-1264	22	23	any	any	DET
ajlm-1264	22	24	data	datum	NOUN
ajlm-1264	22	25	associated	associate	VERB
ajlm-1264	22	26	with	with	ADP
ajlm-1264	22	27	samples	sample	NOUN
ajlm-1264	22	28	.	.	PUNCT
ajlm-1264	23	1	this	this	DET
ajlm-1264	23	2	article	article	NOUN
ajlm-1264	23	3	followed	follow	VERB
ajlm-1264	23	4	all	all	DET
ajlm-1264	23	5	ethical	ethical	ADJ
ajlm-1264	23	6	standards	standard	NOUN
ajlm-1264	23	7	for	for	ADP
ajlm-1264	23	8	research	research	NOUN
ajlm-1264	23	9	without	without	ADP
ajlm-1264	23	10	direct	direct	ADJ
ajlm-1264	23	11	contact	contact	NOUN
ajlm-1264	23	12	with	with	ADP
ajlm-1264	23	13	human	human	ADJ
ajlm-1264	23	14	or	or	CCONJ
ajlm-1264	23	15	animal	animal	NOUN
ajlm-1264	23	16	subjects	subject	NOUN
ajlm-1264	23	17	.	.	PUNCT
ajlm-1264	24	1	project	project	NOUN
ajlm-1264	24	2	design	design	VERB
ajlm-1264	24	3	the	the	DET
ajlm-1264	24	4	uz	uz	PROPN
ajlm-1264	24	5	-	-	PUNCT
ajlm-1264	24	6	ipsl	ipsl	PROPN
ajlm-1264	24	7	utilised	utilise	VERB
ajlm-1264	24	8	the	the	DET
ajlm-1264	24	9	a5279	a5279	PROPN
ajlm-1264	24	10	replicate	replicate	VERB
ajlm-1264	24	11	samples	sample	NOUN
ajlm-1264	24	12	(	(	PUNCT
ajlm-1264	24	13	n	n	NOUN
ajlm-1264	24	14	=	=	SYM
ajlm-1264	24	15	95	95	NUM
ajlm-1264	24	16	)	)	PUNCT
ajlm-1264	24	17	that	that	PRON
ajlm-1264	24	18	were	be	AUX
ajlm-1264	24	19	available	available	ADJ
ajlm-1264	24	20	at	at	ADP
ajlm-1264	24	21	the	the	DET
ajlm-1264	24	22	uz	uz	PROPN
ajlm-1264	24	23	college	college	PROPN
ajlm-1264	24	24	of	of	ADP
ajlm-1264	24	25	health	health	PROPN
ajlm-1264	24	26	sciences	sciences	PROPN
ajlm-1264	24	27	clinical	clinical	ADJ
ajlm-1264	24	28	trial	trial	NOUN
ajlm-1264	24	29	research	research	NOUN
ajlm-1264	24	30	center	center	NOUN
ajlm-1264	24	31	(	(	PUNCT
ajlm-1264	24	32	uzchs	uzchs	NOUN
ajlm-1264	24	33	-	-	PUNCT
ajlm-1264	24	34	ctrc	ctrc	NOUN
ajlm-1264	24	35	)	)	PUNCT
ajlm-1264	24	36	for	for	ADP
ajlm-1264	24	37	cross	cross	NOUN
ajlm-1264	24	38	-	-	NOUN
ajlm-1264	24	39	validation	validation	NOUN
ajlm-1264	24	40	of	of	ADP
ajlm-1264	24	41	nevirapine	nevirapine	ADJ
ajlm-1264	24	42	assays	assay	NOUN
ajlm-1264	24	43	between	between	ADP
ajlm-1264	24	44	the	the	DET
ajlm-1264	24	45	unmc	unmc	NOUN
ajlm-1264	24	46	-	-	PUNCT
ajlm-1264	24	47	psl	psl	PROPN
ajlm-1264	24	48	and	and	CCONJ
ajlm-1264	24	49	the	the	DET
ajlm-1264	24	50	uz	uz	NOUN
ajlm-1264	24	51	-	-	PUNCT
ajlm-1264	24	52	ipsl	ipsl	NOUN
ajlm-1264	24	53	.	.	PUNCT
ajlm-1264	25	1	a5279	a5279	PROPN
ajlm-1264	25	2	was	be	AUX
ajlm-1264	25	3	a	a	DET
ajlm-1264	25	4	multi	multi	ADJ
ajlm-1264	25	5	-	-	ADJ
ajlm-1264	25	6	centre	centre	ADJ
ajlm-1264	25	7	,	,	PUNCT
ajlm-1264	25	8	phase	phase	NOUN
ajlm-1264	25	9	iii	iii	NUM
ajlm-1264	25	10	clinical	clinical	ADJ
ajlm-1264	25	11	trial	trial	NOUN
ajlm-1264	25	12	investigating	investigate	VERB
ajlm-1264	25	13	the	the	DET
ajlm-1264	25	14	use	use	NOUN
ajlm-1264	25	15	of	of	ADP
ajlm-1264	25	16	short	short	ADJ
ajlm-1264	25	17	-	-	PUNCT
ajlm-1264	25	18	course	course	NOUN
ajlm-1264	25	19	rifapentine	rifapentine	NOUN
ajlm-1264	25	20	or	or	CCONJ
ajlm-1264	25	21	isoniazid	isoniazid	NOUN
ajlm-1264	25	22	for	for	ADP
ajlm-1264	25	23	the	the	DET
ajlm-1264	25	24	prevention	prevention	NOUN
ajlm-1264	25	25	of	of	ADP
ajlm-1264	25	26	active	active	ADJ
ajlm-1264	25	27	tuberculosis	tuberculosis	NOUN
ajlm-1264	25	28	in	in	ADP
ajlm-1264	25	29	hiv	hiv	PROPN
ajlm-1264	25	30	-	-	PUNCT
ajlm-1264	25	31	positive	positive	ADJ
ajlm-1264	25	32	adults.6	adults.6	PROPN
ajlm-1264	25	33	in	in	ADP
ajlm-1264	25	34	a5279	a5279	PROPN
ajlm-1264	25	35	,	,	PUNCT
ajlm-1264	25	36	nevirapine	nevirapine	ADJ
ajlm-1264	25	37	pharmacokinetics	pharmacokinetic	NOUN
ajlm-1264	25	38	when	when	SCONJ
ajlm-1264	25	39	co	co	VERB
ajlm-1264	25	40	-	-	VERB
ajlm-1264	25	41	administered	administer	VERB
ajlm-1264	25	42	with	with	ADP
ajlm-1264	25	43	rifapentine	rifapentine	NOUN
ajlm-1264	25	44	and	and	CCONJ
ajlm-1264	25	45	isoniazid	isoniazid	NOUN
ajlm-1264	25	46	was	be	AUX
ajlm-1264	25	47	one	one	NUM
ajlm-1264	25	48	of	of	ADP
ajlm-1264	25	49	the	the	DET
ajlm-1264	25	50	exploratory	exploratory	ADJ
ajlm-1264	25	51	objectives	objective	NOUN
ajlm-1264	25	52	.	.	PUNCT
ajlm-1264	26	1	all	all	DET
ajlm-1264	26	2	a5279	a5279	PROPN
ajlm-1264	26	3	primary	primary	ADJ
ajlm-1264	26	4	aliquots	aliquot	NOUN
ajlm-1264	26	5	collected	collect	VERB
ajlm-1264	26	6	from	from	ADP
ajlm-1264	26	7	the	the	DET
ajlm-1264	26	8	uz	uz	PROPN
ajlm-1264	26	9	aids	aids	PROPN
ajlm-1264	26	10	clinical	clinical	ADJ
ajlm-1264	26	11	trials	trial	NOUN
ajlm-1264	26	12	group	group	NOUN
ajlm-1264	26	13	ctrc	ctrc	NOUN
ajlm-1264	26	14	were	be	AUX
ajlm-1264	26	15	analysed	analyse	VERB
ajlm-1264	26	16	for	for	ADP
ajlm-1264	26	17	nevirapine	nevirapine	ADJ
ajlm-1264	26	18	by	by	ADP
ajlm-1264	26	19	the	the	DET
ajlm-1264	26	20	protocol	protocol	NOUN
ajlm-1264	26	21	designated	designate	VERB
ajlm-1264	26	22	psl	psl	PROPN
ajlm-1264	26	23	at	at	ADP
ajlm-1264	26	24	the	the	DET
ajlm-1264	26	25	unmc	unmc	NOUN
ajlm-1264	26	26	-	-	PUNCT
ajlm-1264	26	27	psl	psl	NOUN
ajlm-1264	26	28	.	.	PUNCT
ajlm-1264	27	1	a5279	a5279	NOUN
ajlm-1264	27	2	sample	sample	NOUN
ajlm-1264	27	3	collection	collection	NOUN
ajlm-1264	27	4	and	and	CCONJ
ajlm-1264	27	5	processing	processing	NOUN
ajlm-1264	27	6	plasma	plasma	NOUN
ajlm-1264	27	7	samples	sample	NOUN
ajlm-1264	27	8	for	for	ADP
ajlm-1264	27	9	the	the	DET
ajlm-1264	27	10	quantitation	quantitation	NOUN
ajlm-1264	27	11	of	of	ADP
ajlm-1264	27	12	nevirapine	nevirapine	ADJ
ajlm-1264	27	13	concentrations	concentration	NOUN
ajlm-1264	27	14	were	be	AUX
ajlm-1264	27	15	obtained	obtain	VERB
ajlm-1264	27	16	from	from	ADP
ajlm-1264	27	17	a5279	a5279	PROPN
ajlm-1264	27	18	study	study	NOUN
ajlm-1264	27	19	participants	participant	NOUN
ajlm-1264	27	20	.	.	PUNCT
ajlm-1264	28	1	blood	blood	NOUN
ajlm-1264	28	2	was	be	AUX
ajlm-1264	28	3	collected	collect	VERB
ajlm-1264	28	4	into	into	ADP
ajlm-1264	28	5	potassium	potassium	NOUN
ajlm-1264	28	6	ethylenediaminetetraacetic	ethylenediaminetetraacetic	ADJ
ajlm-1264	28	7	acid	acid	NOUN
ajlm-1264	28	8	collection	collection	NOUN
ajlm-1264	28	9	tubes	tube	NOUN
ajlm-1264	28	10	and	and	CCONJ
ajlm-1264	28	11	transported	transport	VERB
ajlm-1264	28	12	on	on	ADP
ajlm-1264	28	13	ice	ice	NOUN
ajlm-1264	28	14	to	to	ADP
ajlm-1264	28	15	the	the	DET
ajlm-1264	28	16	processing	processing	NOUN
ajlm-1264	28	17	laboratory	laboratory	NOUN
ajlm-1264	28	18	within	within	ADP
ajlm-1264	28	19	1	1	NUM
ajlm-1264	28	20	h	h	NOUN
ajlm-1264	28	21	where	where	SCONJ
ajlm-1264	28	22	the	the	DET
ajlm-1264	28	23	plasma	plasma	NOUN
ajlm-1264	28	24	was	be	AUX
ajlm-1264	28	25	separated	separate	VERB
ajlm-1264	28	26	from	from	ADP
ajlm-1264	28	27	cells	cell	NOUN
ajlm-1264	28	28	by	by	ADP
ajlm-1264	28	29	centrifugation	centrifugation	NOUN
ajlm-1264	28	30	(	(	PUNCT
ajlm-1264	28	31	1200	1200	NUM
ajlm-1264	28	32	×	×	NOUN
ajlm-1264	28	33	g	g	PROPN
ajlm-1264	28	34	,	,	PUNCT
ajlm-1264	28	35	10	10	NUM
ajlm-1264	28	36	min	min	NOUN
ajlm-1264	28	37	,	,	PUNCT
ajlm-1264	28	38	4	4	NUM
ajlm-1264	28	39	°	°	NOUN
ajlm-1264	28	40	c	c	NOUN
ajlm-1264	28	41	)	)	PUNCT
ajlm-1264	28	42	.	.	PUNCT
ajlm-1264	29	1	the	the	DET
ajlm-1264	29	2	plasma	plasma	NOUN
ajlm-1264	29	3	aliquots	aliquot	NOUN
ajlm-1264	29	4	were	be	AUX
ajlm-1264	29	5	frozen	freeze	VERB
ajlm-1264	29	6	(	(	PUNCT
ajlm-1264	29	7	–	–	PUNCT
ajlm-1264	29	8	70	70	NUM
ajlm-1264	29	9	°	°	NOUN
ajlm-1264	29	10	c	c	NOUN
ajlm-1264	29	11	)	)	PUNCT
ajlm-1264	29	12	and	and	CCONJ
ajlm-1264	29	13	shipped	ship	VERB
ajlm-1264	29	14	to	to	ADP
ajlm-1264	29	15	the	the	DET
ajlm-1264	29	16	unmc	unmc	NOUN
ajlm-1264	29	17	-	-	PUNCT
ajlm-1264	29	18	psl	psl	NOUN
ajlm-1264	29	19	.	.	PUNCT
ajlm-1264	30	1	the	the	DET
ajlm-1264	30	2	uzchs	uzchs	NOUN
ajlm-1264	30	3	-	-	PUNCT
ajlm-1264	30	4	ctrc	ctrc	NOUN
ajlm-1264	30	5	retained	retain	VERB
ajlm-1264	30	6	secondary	secondary	ADJ
ajlm-1264	30	7	aliquots	aliquot	NOUN
ajlm-1264	30	8	for	for	ADP
ajlm-1264	30	9	the	the	DET
ajlm-1264	30	10	uz	uz	PROPN
ajlm-1264	30	11	-	-	PUNCT
ajlm-1264	30	12	ipsl	ipsl	ADJ
ajlm-1264	30	13	cross	cross	ADJ
ajlm-1264	30	14	-	-	ADJ
ajlm-1264	30	15	validation	validation	ADJ
ajlm-1264	30	16	assay	assay	NOUN
ajlm-1264	30	17	.	.	PUNCT
ajlm-1264	31	1	university	university	NOUN
ajlm-1264	31	2	of	of	ADP
ajlm-1264	31	3	nebraska	nebraska	PROPN
ajlm-1264	31	4	medical	medical	PROPN
ajlm-1264	31	5	center	center	PROPN
ajlm-1264	31	6	psl	psl	PROPN
ajlm-1264	31	7	nevirapine	nevirapine	PROPN
ajlm-1264	31	8	assay	assay	PROPN
ajlm-1264	31	9	a5279	a5279	PROPN
ajlm-1264	31	10	primary	primary	ADJ
ajlm-1264	31	11	plasma	plasma	NOUN
ajlm-1264	31	12	aliquots	aliquot	NOUN
ajlm-1264	31	13	were	be	AUX
ajlm-1264	31	14	shipped	ship	VERB
ajlm-1264	31	15	from	from	ADP
ajlm-1264	31	16	uzchs	uzch	NOUN
ajlm-1264	31	17	-	-	PUNCT
ajlm-1264	31	18	ctrc	ctrc	ADJ
ajlm-1264	31	19	on	on	ADP
ajlm-1264	31	20	dry	dry	ADJ
ajlm-1264	31	21	ice	ice	NOUN
ajlm-1264	31	22	to	to	ADP
ajlm-1264	31	23	the	the	DET
ajlm-1264	31	24	unmc	unmc	NOUN
ajlm-1264	31	25	-	-	PUNCT
ajlm-1264	31	26	psl	psl	NOUN
ajlm-1264	31	27	for	for	ADP
ajlm-1264	31	28	determination	determination	NOUN
ajlm-1264	31	29	of	of	ADP
ajlm-1264	31	30	the	the	DET
ajlm-1264	31	31	nevirapine	nevirapine	NOUN
ajlm-1264	31	32	.	.	PUNCT
ajlm-1264	32	1	the	the	DET
ajlm-1264	32	2	unmc	unmc	PROPN
ajlm-1264	32	3	-	-	PUNCT
ajlm-1264	32	4	psl	psl	NOUN
ajlm-1264	32	5	nevirapine	nevirapine	ADJ
ajlm-1264	32	6	determination	determination	NOUN
ajlm-1264	32	7	assay	assay	PROPN
ajlm-1264	32	8	had	have	VERB
ajlm-1264	32	9	a	a	DET
ajlm-1264	32	10	quantitation	quantitation	NOUN
ajlm-1264	32	11	range	range	NOUN
ajlm-1264	32	12	of	of	ADP
ajlm-1264	32	13	25	25	NUM
ajlm-1264	32	14	ng	ng	NOUN
ajlm-1264	32	15	/	/	SYM
ajlm-1264	32	16	ml	ml	NOUN
ajlm-1264	32	17	to	to	ADP
ajlm-1264	32	18	10	10	NUM
ajlm-1264	32	19	000	000	NUM
ajlm-1264	32	20	ng	ng	PROPN
ajlm-1264	32	21	/	/	SYM
ajlm-1264	32	22	ml	ml	NOUN
ajlm-1264	32	23	.	.	PUNCT
ajlm-1264	33	1	samples	sample	NOUN
ajlm-1264	33	2	measuring	measure	VERB
ajlm-1264	33	3	above	above	ADP
ajlm-1264	33	4	the	the	DET
ajlm-1264	33	5	quantitation	quantitation	NOUN
ajlm-1264	33	6	range	range	NOUN
ajlm-1264	33	7	were	be	AUX
ajlm-1264	33	8	diluted	dilute	VERB
ajlm-1264	33	9	and	and	CCONJ
ajlm-1264	33	10	reanalysed	reanalyse	VERB
ajlm-1264	33	11	using	use	VERB
ajlm-1264	33	12	a	a	DET
ajlm-1264	33	13	validated	validated	ADJ
ajlm-1264	33	14	dilution	dilution	NOUN
ajlm-1264	33	15	protocol	protocol	NOUN
ajlm-1264	33	16	.	.	PUNCT
ajlm-1264	34	1	solid	solid	ADJ
ajlm-1264	34	2	-	-	PUNCT
ajlm-1264	34	3	phase	phase	NOUN
ajlm-1264	34	4	extraction	extraction	NOUN
ajlm-1264	34	5	was	be	AUX
ajlm-1264	34	6	utilised	utilise	VERB
ajlm-1264	34	7	to	to	PART
ajlm-1264	34	8	prepare	prepare	VERB
ajlm-1264	34	9	samples	sample	NOUN
ajlm-1264	34	10	for	for	ADP
ajlm-1264	34	11	analysis	analysis	NOUN
ajlm-1264	34	12	.	.	PUNCT
ajlm-1264	35	1	the	the	DET
ajlm-1264	35	2	unmc	unmc	PROPN
ajlm-1264	35	3	-	-	PUNCT
ajlm-1264	35	4	psl	psl	NOUN
ajlm-1264	35	5	utilised	utilise	VERB
ajlm-1264	35	6	a	a	DET
ajlm-1264	35	7	waters	water	NOUN
ajlm-1264	35	8	e2695	e2695	NOUN
ajlm-1264	35	9	hplc	hplc	NOUN
ajlm-1264	35	10	coupled	couple	VERB
ajlm-1264	35	11	to	to	ADP
ajlm-1264	35	12	a	a	DET
ajlm-1264	35	13	waters	water	NOUN
ajlm-1264	35	14	2489	2489	NUM
ajlm-1264	35	15	ultraviolet	ultraviolet	NOUN
ajlm-1264	35	16	(	(	PUNCT
ajlm-1264	35	17	waters	water	NOUN
ajlm-1264	35	18	,	,	PUNCT
ajlm-1264	35	19	milford	milford	PROPN
ajlm-1264	35	20	,	,	PUNCT
ajlm-1264	35	21	massachusetts	massachusetts	PROPN
ajlm-1264	35	22	,	,	PUNCT
ajlm-1264	35	23	united	united	PROPN
ajlm-1264	35	24	states	states	PROPN
ajlm-1264	35	25	)	)	PUNCT
ajlm-1264	35	26	detector	detector	NOUN
ajlm-1264	35	27	,	,	PUNCT
ajlm-1264	35	28	which	which	PRON
ajlm-1264	35	29	was	be	AUX
ajlm-1264	35	30	controlled	control	VERB
ajlm-1264	35	31	with	with	ADP
ajlm-1264	35	32	empower	empower	NOUN
ajlm-1264	35	33	2	2	NUM
ajlm-1264	35	34	(	(	PUNCT
ajlm-1264	35	35	waters	water	NOUN
ajlm-1264	35	36	,	,	PUNCT
ajlm-1264	35	37	milford	milford	PROPN
ajlm-1264	35	38	,	,	PUNCT
ajlm-1264	35	39	massachusetts	massachusetts	PROPN
ajlm-1264	35	40	,	,	PUNCT
ajlm-1264	35	41	united	united	PROPN
ajlm-1264	35	42	states	states	PROPN
ajlm-1264	35	43	)	)	PUNCT
ajlm-1264	35	44	software	software	NOUN
ajlm-1264	35	45	as	as	ADP
ajlm-1264	35	46	the	the	DET
ajlm-1264	35	47	analytical	analytical	ADJ
ajlm-1264	35	48	platform	platform	NOUN
ajlm-1264	35	49	.	.	PUNCT
ajlm-1264	36	1	the	the	DET
ajlm-1264	36	2	performance	performance	NOUN
ajlm-1264	36	3	of	of	ADP
ajlm-1264	36	4	the	the	DET
ajlm-1264	36	5	assay	assay	NOUN
ajlm-1264	36	6	was	be	AUX
ajlm-1264	36	7	compliant	compliant	ADJ
ajlm-1264	36	8	with	with	ADP
ajlm-1264	36	9	the	the	DET
ajlm-1264	36	10	united	united	PROPN
ajlm-1264	36	11	states	states	PROPN
ajlm-1264	36	12	food	food	PROPN
ajlm-1264	36	13	and	and	CCONJ
ajlm-1264	36	14	drug	drug	NOUN
ajlm-1264	36	15	administration	administration	NOUN
ajlm-1264	36	16	bioanalytical	bioanalytical	ADJ
ajlm-1264	36	17	guidelines	guideline	NOUN
ajlm-1264	36	18	for	for	ADP
ajlm-1264	36	19	method	method	NOUN
ajlm-1264	36	20	validation.7	validation.7	PROPN
ajlm-1264	36	21	university	university	PROPN
ajlm-1264	36	22	of	of	ADP
ajlm-1264	36	23	zimbabwe	zimbabwe	PROPN
ajlm-1264	36	24	international	international	PROPN
ajlm-1264	36	25	hiv	hiv	PROPN
ajlm-1264	36	26	psl	psl	PROPN
ajlm-1264	36	27	nevirapine	nevirapine	PROPN
ajlm-1264	36	28	assay	assay	PROPN
ajlm-1264	36	29	replicate	replicate	VERB
ajlm-1264	36	30	plasma	plasma	NOUN
ajlm-1264	36	31	aliquots	aliquot	NOUN
ajlm-1264	36	32	(	(	PUNCT
ajlm-1264	36	33	n	n	NOUN
ajlm-1264	36	34	=	=	SYM
ajlm-1264	36	35	95	95	NUM
ajlm-1264	36	36	)	)	PUNCT
ajlm-1264	36	37	from	from	ADP
ajlm-1264	36	38	a5279	a5279	PROPN
ajlm-1264	36	39	available	available	ADJ
ajlm-1264	36	40	at	at	ADP
ajlm-1264	36	41	the	the	DET
ajlm-1264	36	42	uzchs	uzchs	NOUN
ajlm-1264	36	43	-	-	PUNCT
ajlm-1264	36	44	ctrc	ctrc	NOUN
ajlm-1264	36	45	were	be	AUX
ajlm-1264	36	46	shipped	ship	VERB
ajlm-1264	36	47	to	to	ADP
ajlm-1264	36	48	the	the	DET
ajlm-1264	36	49	uz	uz	NOUN
ajlm-1264	36	50	-	-	PUNCT
ajlm-1264	36	51	ipsl	ipsl	NOUN
ajlm-1264	36	52	for	for	ADP
ajlm-1264	36	53	determination	determination	NOUN
ajlm-1264	36	54	of	of	ADP
ajlm-1264	36	55	the	the	DET
ajlm-1264	36	56	nevirapine	nevirapine	ADJ
ajlm-1264	36	57	concentration	concentration	NOUN
ajlm-1264	36	58	for	for	ADP
ajlm-1264	36	59	cross	cross	NOUN
ajlm-1264	36	60	-	-	NOUN
ajlm-1264	36	61	validation	validation	NOUN
ajlm-1264	36	62	.	.	PUNCT
ajlm-1264	37	1	the	the	DET
ajlm-1264	37	2	uz	uz	PROPN
ajlm-1264	37	3	-	-	PUNCT
ajlm-1264	37	4	ipsl	ipsl	PROPN
ajlm-1264	37	5	measured	measure	VERB
ajlm-1264	37	6	nevirapine	nevirapine	ADJ
ajlm-1264	37	7	using	use	VERB
ajlm-1264	37	8	a	a	DET
ajlm-1264	37	9	validated	validate	VERB
ajlm-1264	37	10	hplc	hplc	NOUN
ajlm-1264	37	11	-	-	PUNCT
ajlm-1264	37	12	ultraviolet	ultraviolet	NOUN
ajlm-1264	37	13	assay	assay	PROPN
ajlm-1264	37	14	detailed	detail	VERB
ajlm-1264	37	15	previously.2	previously.2	NOUN
ajlm-1264	37	16	the	the	DET
ajlm-1264	37	17	uz	uz	NOUN
ajlm-1264	37	18	-	-	PUNCT
ajlm-1264	37	19	ipsl	ipsl	ADJ
ajlm-1264	37	20	chromatographic	chromatographic	ADJ
ajlm-1264	37	21	system	system	NOUN
ajlm-1264	37	22	consisted	consist	VERB
ajlm-1264	37	23	of	of	ADP
ajlm-1264	37	24	a	a	DET
ajlm-1264	37	25	shimadzu	shimadzu	ADJ
ajlm-1264	37	26	lc20a	lc20a	NOUN
ajlm-1264	37	27	hplc	hplc	NOUN
ajlm-1264	37	28	using	use	VERB
ajlm-1264	37	29	ultraviolet	ultraviolet	ADJ
ajlm-1264	37	30	photodiode	photodiode	NOUN
ajlm-1264	37	31	array	array	NOUN
ajlm-1264	37	32	detection	detection	NOUN
ajlm-1264	37	33	(	(	PUNCT
ajlm-1264	37	34	model	model	NOUN
ajlm-1264	37	35	spd	spd	NOUN
ajlm-1264	37	36	-	-	PUNCT
ajlm-1264	37	37	m20a	m20a	NOUN
ajlm-1264	37	38	)	)	PUNCT
ajlm-1264	37	39	and	and	CCONJ
ajlm-1264	37	40	labsolutions	labsolution	NOUN
ajlm-1264	37	41	software	software	NOUN
ajlm-1264	37	42	(	(	PUNCT
ajlm-1264	37	43	version	version	NOUN
ajlm-1264	37	44	5.8	5.8	NUM
ajlm-1264	37	45	;	;	PUNCT
ajlm-1264	37	46	kyoto	kyoto	PROPN
ajlm-1264	37	47	,	,	PUNCT
ajlm-1264	37	48	japan	japan	PROPN
ajlm-1264	37	49	)	)	PUNCT
ajlm-1264	37	50	.	.	PUNCT
ajlm-1264	38	1	the	the	DET
ajlm-1264	38	2	assay	assay	PROPN
ajlm-1264	38	3	quantitation	quantitation	NOUN
ajlm-1264	38	4	range	range	NOUN
ajlm-1264	38	5	was	be	AUX
ajlm-1264	38	6	500	500	NUM
ajlm-1264	38	7	ng	ng	NOUN
ajlm-1264	38	8	/	/	SYM
ajlm-1264	38	9	ml	ml	NOUN
ajlm-1264	38	10	to	to	ADP
ajlm-1264	38	11	15	15	NUM
ajlm-1264	38	12	000	000	NUM
ajlm-1264	38	13	ng	ng	PROPN
ajlm-1264	38	14	/	/	SYM
ajlm-1264	38	15	ml	ml	NOUN
ajlm-1264	38	16	.	.	PUNCT
ajlm-1264	39	1	samples	sample	NOUN
ajlm-1264	39	2	that	that	PRON
ajlm-1264	39	3	were	be	AUX
ajlm-1264	39	4	above	above	ADP
ajlm-1264	39	5	the	the	DET
ajlm-1264	39	6	quantitation	quantitation	NOUN
ajlm-1264	39	7	range	range	NOUN
ajlm-1264	39	8	were	be	AUX
ajlm-1264	39	9	diluted	dilute	VERB
ajlm-1264	39	10	and	and	CCONJ
ajlm-1264	39	11	reanalysed	reanalyse	VERB
ajlm-1264	39	12	.	.	PUNCT
ajlm-1264	40	1	the	the	DET
ajlm-1264	40	2	performance	performance	NOUN
ajlm-1264	40	3	of	of	ADP
ajlm-1264	40	4	the	the	DET
ajlm-1264	40	5	assay	assay	NOUN
ajlm-1264	40	6	was	be	AUX
ajlm-1264	40	7	compliant	compliant	ADJ
ajlm-1264	40	8	with	with	ADP
ajlm-1264	40	9	united	united	PROPN
ajlm-1264	40	10	states	states	PROPN
ajlm-1264	40	11	food	food	PROPN
ajlm-1264	40	12	and	and	CCONJ
ajlm-1264	40	13	drug	drug	NOUN
ajlm-1264	40	14	administration	administration	NOUN
ajlm-1264	40	15	bioanalytical	bioanalytical	ADJ
ajlm-1264	40	16	guidelines	guideline	NOUN
ajlm-1264	40	17	.	.	PUNCT
ajlm-1264	41	1	peak	peak	NOUN
ajlm-1264	41	2	purity	purity	NOUN
ajlm-1264	41	3	for	for	ADP
ajlm-1264	41	4	nevirapine	nevirapine	ADJ
ajlm-1264	41	5	was	be	AUX
ajlm-1264	41	6	assessed	assess	VERB
ajlm-1264	41	7	to	to	PART
ajlm-1264	41	8	confirm	confirm	VERB
ajlm-1264	41	9	the	the	DET
ajlm-1264	41	10	absence	absence	NOUN
ajlm-1264	41	11	of	of	ADP
ajlm-1264	41	12	interferences	interference	NOUN
ajlm-1264	41	13	from	from	ADP
ajlm-1264	41	14	potential	potential	ADJ
ajlm-1264	41	15	impurities	impurity	NOUN
ajlm-1264	41	16	also	also	ADV
ajlm-1264	41	17	extracted	extract	VERB
ajlm-1264	41	18	from	from	ADP
ajlm-1264	41	19	the	the	DET
ajlm-1264	41	20	patient	patient	NOUN
ajlm-1264	41	21	’s	’s	PART
ajlm-1264	41	22	sample	sample	NOUN
ajlm-1264	41	23	.	.	PUNCT
ajlm-1264	42	1	a5279	a5279	NOUN
ajlm-1264	42	2	samples	sample	NOUN
ajlm-1264	42	3	were	be	AUX
ajlm-1264	42	4	assayed	assayed	ADJ
ajlm-1264	42	5	over	over	ADP
ajlm-1264	42	6	five	five	NUM
ajlm-1264	42	7	runs	run	NOUN
ajlm-1264	42	8	;	;	PUNCT
ajlm-1264	42	9	the	the	DET
ajlm-1264	42	10	two	two	NUM
ajlm-1264	42	11	last	last	ADJ
ajlm-1264	42	12	runs	run	NOUN
ajlm-1264	42	13	included	include	VERB
ajlm-1264	42	14	samples	sample	NOUN
ajlm-1264	42	15	that	that	PRON
ajlm-1264	42	16	were	be	AUX
ajlm-1264	42	17	above	above	ADP
ajlm-1264	42	18	the	the	DET
ajlm-1264	42	19	upper	upper	ADJ
ajlm-1264	42	20	limit	limit	NOUN
ajlm-1264	42	21	of	of	ADP
ajlm-1264	42	22	quantification	quantification	NOUN
ajlm-1264	42	23	and	and	CCONJ
ajlm-1264	42	24	were	be	AUX
ajlm-1264	42	25	diluted	dilute	VERB
ajlm-1264	42	26	(	(	PUNCT
ajlm-1264	42	27	1:8	1:8	NUM
ajlm-1264	42	28	)	)	PUNCT
ajlm-1264	42	29	according	accord	VERB
ajlm-1264	42	30	to	to	ADP
ajlm-1264	42	31	the	the	DET
ajlm-1264	42	32	validated	validate	VERB
ajlm-1264	42	33	dilution	dilution	NOUN
ajlm-1264	42	34	protocol.2	protocol.2	PROPN
ajlm-1264	42	35	data	data	NOUN
ajlm-1264	42	36	management	management	NOUN
ajlm-1264	42	37	and	and	CCONJ
ajlm-1264	42	38	analysis	analysis	NOUN
ajlm-1264	42	39	the	the	DET
ajlm-1264	42	40	uz	uz	PROPN
ajlm-1264	42	41	-	-	PUNCT
ajlm-1264	42	42	ipsl	ipsl	ADJ
ajlm-1264	42	43	nevirapine	nevirapine	ADJ
ajlm-1264	42	44	results	result	NOUN
ajlm-1264	42	45	were	be	AUX
ajlm-1264	42	46	submitted	submit	VERB
ajlm-1264	42	47	to	to	ADP
ajlm-1264	42	48	the	the	DET
ajlm-1264	42	49	aids	aids	PROPN
ajlm-1264	42	50	clinical	clinical	ADJ
ajlm-1264	42	51	trials	trial	NOUN
ajlm-1264	42	52	group	group	PROPN
ajlm-1264	42	53	data	data	PROPN
ajlm-1264	42	54	management	management	PROPN
ajlm-1264	42	55	center	center	NOUN
ajlm-1264	42	56	portal	portal	NOUN
ajlm-1264	42	57	using	use	VERB
ajlm-1264	42	58	the	the	DET
ajlm-1264	42	59	data	data	NOUN
ajlm-1264	42	60	submission	submission	NOUN
ajlm-1264	42	61	utility	utility	NOUN
ajlm-1264	42	62	(	(	PUNCT
ajlm-1264	42	63	frontier	frontier	NOUN
ajlm-1264	42	64	science	science	PROPN
ajlm-1264	42	65	foundation	foundation	PROPN
ajlm-1264	42	66	inc	inc	PROPN
ajlm-1264	42	67	.	.	PROPN
ajlm-1264	42	68	,	,	PUNCT
ajlm-1264	42	69	brookline	brookline	PROPN
ajlm-1264	42	70	,	,	PUNCT
ajlm-1264	42	71	massachusetts	massachusetts	PROPN
ajlm-1264	42	72	,	,	PUNCT
ajlm-1264	42	73	united	united	PROPN
ajlm-1264	42	74	states	states	PROPN
ajlm-1264	42	75	)	)	PUNCT
ajlm-1264	42	76	.	.	PUNCT
ajlm-1264	43	1	the	the	DET
ajlm-1264	43	2	a5279	a5279	PROPN
ajlm-1264	43	3	study	study	NOUN
ajlm-1264	43	4	team	team	NOUN
ajlm-1264	43	5	approved	approve	VERB
ajlm-1264	43	6	the	the	DET
ajlm-1264	43	7	release	release	NOUN
ajlm-1264	43	8	of	of	ADP
ajlm-1264	43	9	the	the	DET
ajlm-1264	43	10	unmc	unmc	PROPN
ajlm-1264	43	11	a5279	a5279	PROPN
ajlm-1264	43	12	nevirapine	nevirapine	ADJ
ajlm-1264	43	13	concentration	concentration	NOUN
ajlm-1264	43	14	results	result	NOUN
ajlm-1264	43	15	for	for	ADP
ajlm-1264	43	16	comparison	comparison	NOUN
ajlm-1264	43	17	with	with	ADP
ajlm-1264	43	18	the	the	DET
ajlm-1264	43	19	uz	uz	NOUN
ajlm-1264	43	20	-	-	PUNCT
ajlm-1264	43	21	ipsl	ipsl	ADJ
ajlm-1264	43	22	results	result	NOUN
ajlm-1264	43	23	.	.	PUNCT
ajlm-1264	44	1	the	the	DET
ajlm-1264	44	2	original	original	ADJ
ajlm-1264	44	3	nevirapine	nevirapine	ADJ
ajlm-1264	44	4	concentration	concentration	NOUN
ajlm-1264	44	5	data	datum	NOUN
ajlm-1264	44	6	from	from	ADP
ajlm-1264	44	7	the	the	DET
ajlm-1264	44	8	unmc	unmc	NOUN
ajlm-1264	44	9	-	-	PUNCT
ajlm-1264	44	10	psl	psl	PROPN
ajlm-1264	44	11	were	be	AUX
ajlm-1264	44	12	used	use	VERB
ajlm-1264	44	13	in	in	ADP
ajlm-1264	44	14	the	the	DET
ajlm-1264	44	15	specified	specified	ADJ
ajlm-1264	44	16	a5279	a5279	PROPN
ajlm-1264	44	17	protocol	protocol	NOUN
ajlm-1264	44	18	pharmacokinetics	pharmacokinetic	NOUN
ajlm-1264	44	19	analysis	analysis	NOUN
ajlm-1264	44	20	;	;	PUNCT
ajlm-1264	44	21	no	no	DET
ajlm-1264	44	22	uz	uz	NOUN
ajlm-1264	44	23	-	-	PUNCT
ajlm-1264	44	24	ipsl	ipsl	ADJ
ajlm-1264	44	25	derived	derive	VERB
ajlm-1264	44	26	pharmacokinetics	pharmacokinetic	NOUN
ajlm-1264	44	27	data	datum	NOUN
ajlm-1264	44	28	were	be	AUX
ajlm-1264	44	29	used	use	VERB
ajlm-1264	44	30	in	in	ADP
ajlm-1264	44	31	the	the	DET
ajlm-1264	44	32	per	per	ADP
ajlm-1264	44	33	-	-	PUNCT
ajlm-1264	44	34	protocol	protocol	NOUN
ajlm-1264	44	35	study	study	NOUN
ajlm-1264	44	36	analysis	analysis	NOUN
ajlm-1264	44	37	.	.	PUNCT
ajlm-1264	45	1	the	the	DET
ajlm-1264	45	2	data	data	PROPN
ajlm-1264	45	3	management	management	NOUN
ajlm-1264	45	4	center	center	NOUN
ajlm-1264	45	5	compiled	compile	VERB
ajlm-1264	45	6	the	the	DET
ajlm-1264	45	7	data	datum	NOUN
ajlm-1264	45	8	and	and	CCONJ
ajlm-1264	45	9	provided	provide	VERB
ajlm-1264	45	10	the	the	DET
ajlm-1264	45	11	de	de	ADJ
ajlm-1264	45	12	-	-	ADJ
ajlm-1264	45	13	identified	identify	VERB
ajlm-1264	45	14	data	data	NOUN
ajlm-1264	45	15	files	file	NOUN
ajlm-1264	45	16	to	to	ADP
ajlm-1264	45	17	the	the	DET
ajlm-1264	45	18	clinical	clinical	ADJ
ajlm-1264	45	19	pharmacology	pharmacology	NOUN
ajlm-1264	45	20	quality	quality	NOUN
ajlm-1264	45	21	assurance	assurance	NOUN
ajlm-1264	45	22	pt	pt	NOUN
ajlm-1264	45	23	unit	unit	NOUN
ajlm-1264	45	24	to	to	PART
ajlm-1264	45	25	perform	perform	VERB
ajlm-1264	45	26	blinded	blind	VERB
ajlm-1264	45	27	,	,	PUNCT
ajlm-1264	45	28	comparative	comparative	ADJ
ajlm-1264	45	29	statistical	statistical	ADJ
ajlm-1264	45	30	analyses	analysis	NOUN
ajlm-1264	45	31	of	of	ADP
ajlm-1264	45	32	the	the	DET
ajlm-1264	45	33	nevirapine	nevirapine	ADJ
ajlm-1264	45	34	results	result	NOUN
ajlm-1264	45	35	.	.	PUNCT
ajlm-1264	46	1	after	after	ADP
ajlm-1264	46	2	examination	examination	NOUN
ajlm-1264	46	3	(	(	PUNCT
ajlm-1264	46	4	omnibus	omnibus	NOUN
ajlm-1264	46	5	2	2	NUM
ajlm-1264	46	6	)	)	PUNCT
ajlm-1264	46	7	and	and	CCONJ
ajlm-1264	46	8	finalisation	finalisation	NOUN
ajlm-1264	46	9	of	of	ADP
ajlm-1264	46	10	the	the	DET
ajlm-1264	46	11	data	datum	NOUN
ajlm-1264	46	12	,	,	PUNCT
ajlm-1264	46	13	the	the	DET
ajlm-1264	46	14	analyses	analysis	NOUN
ajlm-1264	46	15	of	of	ADP
ajlm-1264	46	16	the	the	DET
ajlm-1264	46	17	paired	pair	VERB
ajlm-1264	46	18	t	t	NOUN
ajlm-1264	46	19	-	-	PUNCT
ajlm-1264	46	20	test	test	NOUN
ajlm-1264	46	21	,	,	PUNCT
ajlm-1264	46	22	deming	deming	PROPN
ajlm-1264	46	23	regression	regression	PROPN
ajlm-1264	46	24	and	and	CCONJ
ajlm-1264	46	25	bland	bland	ADJ
ajlm-1264	46	26	-	-	PUNCT
ajlm-1264	46	27	altman	altman	NOUN
ajlm-1264	46	28	analyses	analysis	NOUN
ajlm-1264	46	29	were	be	AUX
ajlm-1264	46	30	completed	complete	VERB
ajlm-1264	46	31	using	use	VERB
ajlm-1264	46	32	prism	prism	NOUN
ajlm-1264	46	33	graphpad	graphpad	NOUN
ajlm-1264	46	34	(	(	PUNCT
ajlm-1264	46	35	version	version	NOUN
ajlm-1264	46	36	8.3	8.3	NUM
ajlm-1264	46	37	;	;	PUNCT
ajlm-1264	46	38	san	san	PROPN
ajlm-1264	46	39	diego	diego	PROPN
ajlm-1264	46	40	,	,	PUNCT
ajlm-1264	46	41	california	california	PROPN
ajlm-1264	46	42	,	,	PUNCT
ajlm-1264	46	43	united	united	PROPN
ajlm-1264	46	44	states	states	PROPN
ajlm-1264	46	45	)	)	PUNCT
ajlm-1264	46	46	software	software	NOUN
ajlm-1264	46	47	.	.	PUNCT
ajlm-1264	47	1	results	result	VERB
ajlm-1264	47	2	ninety	ninety	NUM
ajlm-1264	47	3	-	-	PUNCT
ajlm-1264	47	4	five	five	NUM
ajlm-1264	47	5	replicate	replicate	ADJ
ajlm-1264	47	6	plasma	plasma	NOUN
ajlm-1264	47	7	aliquots	aliquot	NOUN
ajlm-1264	47	8	were	be	AUX
ajlm-1264	47	9	bioanalysed	bioanalyse	VERB
ajlm-1264	47	10	.	.	PUNCT
ajlm-1264	48	1	the	the	DET
ajlm-1264	48	2	nevirapine	nevirapine	ADJ
ajlm-1264	48	3	concentration	concentration	NOUN
ajlm-1264	48	4	range	range	NOUN
ajlm-1264	48	5	in	in	ADP
ajlm-1264	48	6	the	the	DET
ajlm-1264	48	7	analysed	analyse	VERB
ajlm-1264	48	8	samples	sample	NOUN
ajlm-1264	48	9	was	be	AUX
ajlm-1264	48	10	~2000	~2000	NUM
ajlm-1264	48	11	ng	ng	NOUN
ajlm-1264	48	12	/	/	SYM
ajlm-1264	48	13	ml	ml	PROPN
ajlm-1264	48	14	–	–	PUNCT
ajlm-1264	48	15	34	34	NUM
ajlm-1264	48	16	000	000	NUM
ajlm-1264	48	17	ng	ng	PROPN
ajlm-1264	48	18	/	/	SYM
ajlm-1264	48	19	ml	ml	PROPN
ajlm-1264	49	1	(	(	PUNCT
ajlm-1264	50	1	~17	~17	NOUN
ajlm-1264	50	2	-	-	ADJ
ajlm-1264	50	3	fold	fold	ADJ
ajlm-1264	50	4	)	)	PUNCT
ajlm-1264	50	5	.	.	PUNCT
ajlm-1264	51	1	of	of	ADP
ajlm-1264	51	2	this	this	PRON
ajlm-1264	51	3	,	,	PUNCT
ajlm-1264	51	4	97	97	NUM
ajlm-1264	51	5	%	%	NOUN
ajlm-1264	51	6	(	(	PUNCT
ajlm-1264	51	7	n	n	NOUN
ajlm-1264	51	8	=	=	SYM
ajlm-1264	51	9	92	92	NUM
ajlm-1264	51	10	)	)	PUNCT
ajlm-1264	51	11	ranged	range	VERB
ajlm-1264	51	12	between	between	ADP
ajlm-1264	51	13	2000	2000	NUM
ajlm-1264	51	14	ng	ng	PROPN
ajlm-1264	51	15	/	/	SYM
ajlm-1264	51	16	ml	ml	PROPN
ajlm-1264	51	17	and	and	CCONJ
ajlm-1264	51	18	20	20	NUM
ajlm-1264	51	19	000	000	NUM
ajlm-1264	51	20	ng	ng	PROPN
ajlm-1264	51	21	/	/	SYM
ajlm-1264	51	22	ml	ml	PROPN
ajlm-1264	51	23	and	and	CCONJ
ajlm-1264	51	24	the	the	DET
ajlm-1264	51	25	remaining	remain	VERB
ajlm-1264	51	26	3	3	NUM
ajlm-1264	51	27	%	%	NOUN
ajlm-1264	51	28	(	(	PUNCT
ajlm-1264	51	29	n	n	NOUN
ajlm-1264	51	30	=	=	SYM
ajlm-1264	51	31	3	3	NUM
ajlm-1264	51	32	)	)	PUNCT
ajlm-1264	51	33	were	be	AUX
ajlm-1264	51	34	above	above	ADP
ajlm-1264	51	35	20	20	NUM
ajlm-1264	51	36	000	000	NUM
ajlm-1264	51	37	ng	ng	PROPN
ajlm-1264	51	38	/	/	SYM
ajlm-1264	51	39	ml	ml	PROPN
ajlm-1264	51	40	and	and	CCONJ
ajlm-1264	51	41	not	not	PART
ajlm-1264	51	42	contiguous	contiguous	ADJ
ajlm-1264	51	43	(	(	PUNCT
ajlm-1264	51	44	table	table	NOUN
ajlm-1264	51	45	1	1	NUM
ajlm-1264	51	46	,	,	PUNCT
ajlm-1264	51	47	figure	figure	VERB
ajlm-1264	51	48	1a)9	1a)9	NUM
ajlm-1264	51	49	.	.	PUNCT
ajlm-1264	52	1	the	the	DET
ajlm-1264	52	2	nevirapine	nevirapine	ADJ
ajlm-1264	52	3	concentration	concentration	NOUN
ajlm-1264	52	4	values	value	NOUN
ajlm-1264	52	5	from	from	ADP
ajlm-1264	52	6	the	the	DET
ajlm-1264	52	7	laboratories	laboratory	NOUN
ajlm-1264	52	8	were	be	AUX
ajlm-1264	52	9	tested	test	VERB
ajlm-1264	52	10	for	for	ADP
ajlm-1264	52	11	normality	normality	NOUN
ajlm-1264	52	12	and	and	CCONJ
ajlm-1264	52	13	only	only	ADV
ajlm-1264	52	14	data	datum	NOUN
ajlm-1264	52	15	≤	≤	NUM
ajlm-1264	52	16	15	15	NUM
ajlm-1264	52	17	000	000	NUM
ajlm-1264	52	18	ng	ng	PROPN
ajlm-1264	52	19	/	/	SYM
ajlm-1264	52	20	ml	ml	NOUN
ajlm-1264	52	21	or	or	CCONJ
ajlm-1264	52	22	less	less	ADJ
ajlm-1264	52	23	were	be	AUX
ajlm-1264	52	24	normally	normally	ADV
ajlm-1264	52	25	distributed	distribute	VERB
ajlm-1264	52	26	.	.	PUNCT
ajlm-1264	53	1	data	datum	NOUN
ajlm-1264	53	2	15	15	NUM
ajlm-1264	53	3	000	000	NUM
ajlm-1264	53	4	ng	ng	PROPN
ajlm-1264	53	5	/	/	SYM
ajlm-1264	53	6	ml	ml	PROPN
ajlm-1264	53	7	reflected	reflect	VERB
ajlm-1264	53	8	the	the	DET
ajlm-1264	53	9	upper	upper	ADJ
ajlm-1264	53	10	limit	limit	NOUN
ajlm-1264	53	11	of	of	ADP
ajlm-1264	53	12	the	the	DET
ajlm-1264	53	13	uz	uz	NOUN
ajlm-1264	53	14	-	-	PUNCT
ajlm-1264	53	15	ipsl	ipsl	ADJ
ajlm-1264	53	16	assay	assay	NOUN
ajlm-1264	53	17	and	and	CCONJ
ajlm-1264	53	18	was	be	AUX
ajlm-1264	53	19	appropriate	appropriate	ADJ
ajlm-1264	53	20	because	because	SCONJ
ajlm-1264	53	21	it	it	PRON
ajlm-1264	53	22	more	more	ADV
ajlm-1264	53	23	closely	closely	ADV
ajlm-1264	53	24	represented	represent	VERB
ajlm-1264	53	25	the	the	DET
ajlm-1264	53	26	previously	previously	ADV
ajlm-1264	53	27	reported	report	VERB
ajlm-1264	53	28	nevirapine	nevirapine	ADJ
ajlm-1264	53	29	steady	steady	ADJ
ajlm-1264	53	30	state	state	NOUN
ajlm-1264	53	31	concentrations	concentration	NOUN
ajlm-1264	53	32	(	(	PUNCT
ajlm-1264	53	33	5086	5086	NUM
ajlm-1264	53	34	ng	ng	NOUN
ajlm-1264	53	35	/	/	SYM
ajlm-1264	53	36	ml	ml	PROPN
ajlm-1264	53	37	–	–	PUNCT
ajlm-1264	53	38	13	13	NUM
ajlm-1264	53	39	368	368	NUM
ajlm-1264	53	40	ng	ng	NOUN
ajlm-1264	53	41	/	/	SYM
ajlm-1264	53	42	ml	ml	PROPN
ajlm-1264	53	43	or	or	CCONJ
ajlm-1264	53	44	19.1	19.1	NUM
ajlm-1264	53	45	um	um	INTJ
ajlm-1264	53	46	to	to	ADP
ajlm-1264	53	47	50.2	50.2	NUM
ajlm-1264	53	48	um).3,4,5	um).3,4,5	NOUN
ajlm-1264	53	49	of	of	ADP
ajlm-1264	53	50	the	the	DET
ajlm-1264	53	51	data	datum	NOUN
ajlm-1264	53	52	,	,	PUNCT
ajlm-1264	53	53	93	93	NUM
ajlm-1264	53	54	%	%	NOUN
ajlm-1264	53	55	(	(	PUNCT
ajlm-1264	53	56	n	n	NOUN
ajlm-1264	53	57	=	=	SYM
ajlm-1264	53	58	88	88	NUM
ajlm-1264	53	59	)	)	PUNCT
ajlm-1264	53	60	were	be	AUX
ajlm-1264	53	61	15	15	NUM
ajlm-1264	53	62	000	000	NUM
ajlm-1264	53	63	ng	ng	PROPN
ajlm-1264	53	64	/	/	SYM
ajlm-1264	53	65	ml	ml	NOUN
ajlm-1264	53	66	or	or	CCONJ
ajlm-1264	53	67	less	less	ADJ
ajlm-1264	53	68	(	(	PUNCT
ajlm-1264	53	69	table	table	NOUN
ajlm-1264	53	70	1)9	1)9	NUM
ajlm-1264	53	71	while	while	SCONJ
ajlm-1264	53	72	7	7	NUM
ajlm-1264	53	73	%	%	NOUN
ajlm-1264	53	74	(	(	PUNCT
ajlm-1264	53	75	n	n	NOUN
ajlm-1264	53	76	=	=	SYM
ajlm-1264	53	77	7	7	X
ajlm-1264	53	78	)	)	PUNCT
ajlm-1264	53	79	were	be	AUX
ajlm-1264	53	80	above	above	ADP
ajlm-1264	53	81	this	this	DET
ajlm-1264	53	82	value	value	NOUN
ajlm-1264	53	83	.	.	PUNCT
ajlm-1264	54	1	therefore	therefore	ADV
ajlm-1264	54	2	,	,	PUNCT
ajlm-1264	54	3	the	the	DET
ajlm-1264	54	4	seven	seven	NUM
ajlm-1264	54	5	sample	sample	NOUN
ajlm-1264	54	6	pairs	pair	NOUN
ajlm-1264	54	7	were	be	AUX
ajlm-1264	54	8	excluded	exclude	VERB
ajlm-1264	54	9	from	from	ADP
ajlm-1264	54	10	the	the	DET
ajlm-1264	54	11	method	method	ADJ
ajlm-1264	54	12	comparison	comparison	NOUN
ajlm-1264	54	13	.	.	PUNCT
ajlm-1264	55	1	after	after	ADP
ajlm-1264	55	2	exclusion	exclusion	NOUN
ajlm-1264	55	3	,	,	PUNCT
ajlm-1264	55	4	an	an	DET
ajlm-1264	55	5	additional	additional	ADJ
ajlm-1264	55	6	sample	sample	NOUN
ajlm-1264	55	7	pair	pair	NOUN
ajlm-1264	55	8	was	be	AUX
ajlm-1264	55	9	identified	identify	VERB
ajlm-1264	55	10	as	as	ADP
ajlm-1264	55	11	a	a	DET
ajlm-1264	55	12	significant	significant	ADJ
ajlm-1264	55	13	outlier	outlier	NOUN
ajlm-1264	55	14	using	use	VERB
ajlm-1264	55	15	the	the	DET
ajlm-1264	55	16	grubbs	grubbs	PROPN
ajlm-1264	55	17	test	test	NOUN
ajlm-1264	55	18	and	and	CCONJ
ajlm-1264	55	19	was	be	AUX
ajlm-1264	55	20	also	also	ADV
ajlm-1264	55	21	excluded	exclude	VERB
ajlm-1264	55	22	.	.	PUNCT
ajlm-1264	56	1	figure	figure	NOUN
ajlm-1264	56	2	1	1	NUM
ajlm-1264	56	3	:	:	PUNCT
ajlm-1264	56	4	differences	difference	NOUN
ajlm-1264	56	5	in	in	ADP
ajlm-1264	56	6	nevirapine	nevirapine	ADJ
ajlm-1264	56	7	concentrations	concentration	NOUN
ajlm-1264	56	8	assayed	assayed	ADJ
ajlm-1264	56	9	at	at	ADP
ajlm-1264	56	10	unmc	unmc	NOUN
ajlm-1264	56	11	-	-	PUNCT
ajlm-1264	56	12	psl	psl	PROPN
ajlm-1264	56	13	(	(	PUNCT
ajlm-1264	56	14	omaha	omaha	PROPN
ajlm-1264	56	15	,	,	PUNCT
ajlm-1264	56	16	nebraska	nebraska	PROPN
ajlm-1264	56	17	,	,	PUNCT
ajlm-1264	56	18	united	united	PROPN
ajlm-1264	56	19	states	states	PROPN
ajlm-1264	56	20	,	,	PUNCT
ajlm-1264	56	21	october	october	PROPN
ajlm-1264	56	22	2017	2017	NUM
ajlm-1264	56	23	)	)	PUNCT
ajlm-1264	56	24	and	and	CCONJ
ajlm-1264	56	25	uz	uz	NOUN
ajlm-1264	56	26	-	-	PUNCT
ajlm-1264	56	27	ipsl	ipsl	PROPN
ajlm-1264	56	28	(	(	PUNCT
ajlm-1264	56	29	harare	harare	PROPN
ajlm-1264	56	30	,	,	PUNCT
ajlm-1264	56	31	zimbabwe	zimbabwe	PROPN
ajlm-1264	56	32	,	,	PUNCT
ajlm-1264	56	33	may	may	PROPN
ajlm-1264	56	34	2018	2018	NUM
ajlm-1264	56	35	)	)	PUNCT
ajlm-1264	56	36	;	;	PUNCT
ajlm-1264	56	37	(	(	PUNCT
ajlm-1264	56	38	a	a	X
ajlm-1264	56	39	)	)	PUNCT
ajlm-1264	56	40	scatter	scatter	NOUN
ajlm-1264	56	41	plot	plot	NOUN
ajlm-1264	56	42	(	(	PUNCT
ajlm-1264	56	43	n	n	NOUN
ajlm-1264	56	44	=	=	SYM
ajlm-1264	56	45	95	95	NUM
ajlm-1264	56	46	data	datum	NOUN
ajlm-1264	56	47	points	point	NOUN
ajlm-1264	56	48	)	)	PUNCT
ajlm-1264	56	49	.	.	PUNCT
ajlm-1264	57	1	(	(	PUNCT
ajlm-1264	57	2	b	b	X
ajlm-1264	57	3	)	)	PUNCT
ajlm-1264	57	4	deming	deming	NOUN
ajlm-1264	57	5	regression	regression	NOUN
ajlm-1264	57	6	plot	plot	NOUN
ajlm-1264	57	7	of	of	ADP
ajlm-1264	57	8	87	87	NUM
ajlm-1264	57	9	data	datum	NOUN
ajlm-1264	57	10	points	point	NOUN
ajlm-1264	57	11	(	(	PUNCT
ajlm-1264	57	12	outliers	outlier	NOUN
ajlm-1264	57	13	excluded	exclude	VERB
ajlm-1264	57	14	)	)	PUNCT
ajlm-1264	57	15	.	.	PUNCT
ajlm-1264	58	1	boxes	box	NOUN
ajlm-1264	58	2	in	in	ADP
ajlm-1264	58	3	(	(	PUNCT
ajlm-1264	58	4	a	a	X
ajlm-1264	58	5	)	)	PUNCT
ajlm-1264	58	6	indicate	indicate	VERB
ajlm-1264	58	7	unmc	unmc	PROPN
ajlm-1264	58	8	upper	upper	ADJ
ajlm-1264	58	9	limit	limit	NOUN
ajlm-1264	58	10	of	of	ADP
ajlm-1264	58	11	quantitation	quantitation	NOUN
ajlm-1264	58	12	(	(	PUNCT
ajlm-1264	58	13	dashed	dash	VERB
ajlm-1264	58	14	)	)	PUNCT
ajlm-1264	58	15	and	and	CCONJ
ajlm-1264	58	16	uz	uz	NOUN
ajlm-1264	58	17	-	-	PUNCT
ajlm-1264	58	18	ipls	ipls	NOUN
ajlm-1264	58	19	upper	upper	ADJ
ajlm-1264	58	20	limit	limit	NOUN
ajlm-1264	58	21	of	of	ADP
ajlm-1264	58	22	quantitation	quantitation	NOUN
ajlm-1264	58	23	(	(	PUNCT
ajlm-1264	58	24	solid	solid	ADJ
ajlm-1264	58	25	lines	line	NOUN
ajlm-1264	58	26	)	)	PUNCT
ajlm-1264	58	27	.	.	PUNCT
ajlm-1264	59	1	table	table	NOUN
ajlm-1264	59	2	1	1	NUM
ajlm-1264	59	3	:	:	PUNCT
ajlm-1264	59	4	 	 	SPACE
ajlm-1264	59	5	a	a	DET
ajlm-1264	59	6	comparative	comparative	ADJ
ajlm-1264	59	7	study	study	NOUN
ajlm-1264	59	8	of	of	ADP
ajlm-1264	59	9	nevirapine	nevirapine	PROPN
ajlm-1264	59	10	assay	assay	PROPN
ajlm-1264	59	11	results	result	NOUN
ajlm-1264	59	12	conducted	conduct	VERB
ajlm-1264	59	13	at	at	ADP
ajlm-1264	59	14	the	the	DET
ajlm-1264	59	15	university	university	PROPN
ajlm-1264	59	16	of	of	ADP
ajlm-1264	59	17	zimbabwe	zimbabwe	PROPN
ajlm-1264	59	18	international	international	PROPN
ajlm-1264	59	19	hiv	hiv	PROPN
ajlm-1264	59	20	pharmacology	pharmacology	NOUN
ajlm-1264	59	21	specialty	specialty	NOUN
ajlm-1264	59	22	laboratory	laboratory	PROPN
ajlm-1264	59	23	(	(	PUNCT
ajlm-1264	59	24	harare	harare	PROPN
ajlm-1264	59	25	,	,	PUNCT
ajlm-1264	59	26	zimbabwe	zimbabwe	PROPN
ajlm-1264	59	27	,	,	PUNCT
ajlm-1264	59	28	may	may	PROPN
ajlm-1264	59	29	2018	2018	NUM
ajlm-1264	59	30	)	)	PUNCT
ajlm-1264	59	31	and	and	CCONJ
ajlm-1264	59	32	the	the	DET
ajlm-1264	59	33	university	university	PROPN
ajlm-1264	59	34	of	of	ADP
ajlm-1264	59	35	nebraska	nebraska	PROPN
ajlm-1264	59	36	medical	medical	PROPN
ajlm-1264	59	37	center	center	PROPN
ajlm-1264	59	38	pharmacology	pharmacology	NOUN
ajlm-1264	59	39	specialty	specialty	NOUN
ajlm-1264	59	40	laboratory	laboratory	NOUN
ajlm-1264	59	41	(	(	PUNCT
ajlm-1264	59	42	omaha	omaha	PROPN
ajlm-1264	59	43	,	,	PUNCT
ajlm-1264	59	44	nebraska	nebraska	PROPN
ajlm-1264	59	45	,	,	PUNCT
ajlm-1264	59	46	united	united	PROPN
ajlm-1264	59	47	states	states	PROPN
ajlm-1264	59	48	,	,	PUNCT
ajlm-1264	59	49	october	october	PROPN
ajlm-1264	59	50	,	,	PUNCT
ajlm-1264	59	51	2017	2017	NUM
ajlm-1264	59	52	)	)	PUNCT
ajlm-1264	59	53	.	.	PUNCT
ajlm-1264	60	1	the	the	DET
ajlm-1264	60	2	two	two	NUM
ajlm-1264	60	3	-	-	PUNCT
ajlm-1264	60	4	tailed	tail	VERB
ajlm-1264	60	5	paired	pair	VERB
ajlm-1264	60	6	t	t	NOUN
ajlm-1264	60	7	-	-	PUNCT
ajlm-1264	60	8	test	test	NOUN
ajlm-1264	60	9	of	of	ADP
ajlm-1264	60	10	the	the	DET
ajlm-1264	60	11	final	final	ADJ
ajlm-1264	60	12	data	datum	NOUN
ajlm-1264	60	13	set	set	NOUN
ajlm-1264	60	14	(	(	PUNCT
ajlm-1264	60	15	n	n	NOUN
ajlm-1264	60	16	=	=	SYM
ajlm-1264	60	17	87	87	NUM
ajlm-1264	60	18	)	)	PUNCT
ajlm-1264	60	19	(	(	PUNCT
ajlm-1264	60	20	table	table	NOUN
ajlm-1264	60	21	1)9	1)9	NUM
ajlm-1264	60	22	showed	show	VERB
ajlm-1264	60	23	uz	uz	NOUN
ajlm-1264	60	24	-	-	PUNCT
ajlm-1264	60	25	ipsl	ipsl	ADJ
ajlm-1264	60	26	nevirapine	nevirapine	ADJ
ajlm-1264	60	27	values	value	NOUN
ajlm-1264	60	28	were	be	AUX
ajlm-1264	60	29	significantly	significantly	ADV
ajlm-1264	60	30	higher	high	ADJ
ajlm-1264	60	31	with	with	ADP
ajlm-1264	60	32	a	a	DET
ajlm-1264	60	33	constant	constant	ADJ
ajlm-1264	60	34	error	error	NOUN
ajlm-1264	60	35	of	of	ADP
ajlm-1264	60	36	3	3	NUM
ajlm-1264	60	37	%	%	NOUN
ajlm-1264	60	38	–	–	PUNCT
ajlm-1264	60	39	4	4	NUM
ajlm-1264	60	40	%	%	NOUN
ajlm-1264	60	41	more	more	ADJ
ajlm-1264	60	42	than	than	ADP
ajlm-1264	60	43	unmc	unmc	NOUN
ajlm-1264	60	44	-	-	PUNCT
ajlm-1264	60	45	psl	psl	NOUN
ajlm-1264	60	46	values	value	NOUN
ajlm-1264	60	47	.	.	PUNCT
ajlm-1264	61	1	the	the	DET
ajlm-1264	61	2	deming	deming	PROPN
ajlm-1264	61	3	regression	regression	NOUN
ajlm-1264	61	4	analysis	analysis	NOUN
ajlm-1264	61	5	(	(	PUNCT
ajlm-1264	61	6	figure	figure	NOUN
ajlm-1264	61	7	1b)9	1b)9	NUM
ajlm-1264	61	8	and	and	CCONJ
ajlm-1264	61	9	the	the	DET
ajlm-1264	61	10	bland	bland	ADJ
ajlm-1264	61	11	-	-	PUNCT
ajlm-1264	61	12	altman	altman	NOUN
ajlm-1264	61	13	plots	plot	NOUN
ajlm-1264	61	14	(	(	PUNCT
ajlm-1264	61	15	figure	figure	NOUN
ajlm-1264	61	16	2)9	2)9	PROPN
ajlm-1264	61	17	further	far	ADV
ajlm-1264	61	18	confirmed	confirm	VERB
ajlm-1264	61	19	the	the	DET
ajlm-1264	61	20	higher	high	ADJ
ajlm-1264	61	21	values	value	NOUN
ajlm-1264	61	22	from	from	ADP
ajlm-1264	61	23	the	the	DET
ajlm-1264	61	24	uz	uz	NOUN
ajlm-1264	61	25	-	-	PUNCT
ajlm-1264	61	26	ipsl	ipsl	NOUN
ajlm-1264	61	27	.	.	PUNCT
ajlm-1264	62	1	as	as	SCONJ
ajlm-1264	62	2	shown	show	VERB
ajlm-1264	62	3	in	in	ADP
ajlm-1264	62	4	figure	figure	NOUN
ajlm-1264	62	5	2a9	2a9	NUM
ajlm-1264	62	6	,	,	PUNCT
ajlm-1264	62	7	regression	regression	VERB
ajlm-1264	62	8	analysis	analysis	NOUN
ajlm-1264	62	9	using	use	VERB
ajlm-1264	62	10	the	the	DET
ajlm-1264	62	11	difference	difference	NOUN
ajlm-1264	62	12	plot	plot	NOUN
ajlm-1264	62	13	indicated	indicate	VERB
ajlm-1264	62	14	an	an	DET
ajlm-1264	62	15	increasing	increase	VERB
ajlm-1264	62	16	proportional	proportional	ADJ
ajlm-1264	62	17	difference	difference	NOUN
ajlm-1264	62	18	between	between	ADP
ajlm-1264	62	19	the	the	DET
ajlm-1264	62	20	clinical	clinical	ADJ
ajlm-1264	62	21	pharmacology	pharmacology	NOUN
ajlm-1264	62	22	laboratories	laboratory	NOUN
ajlm-1264	62	23	as	as	ADP
ajlm-1264	62	24	the	the	DET
ajlm-1264	62	25	concentration	concentration	NOUN
ajlm-1264	62	26	of	of	ADP
ajlm-1264	62	27	nevirapine	nevirapine	PROPN
ajlm-1264	62	28	increased	increase	VERB
ajlm-1264	62	29	.	.	PUNCT
ajlm-1264	63	1	however	however	ADV
ajlm-1264	63	2	,	,	PUNCT
ajlm-1264	63	3	when	when	SCONJ
ajlm-1264	63	4	the	the	DET
ajlm-1264	63	5	data	datum	NOUN
ajlm-1264	63	6	were	be	AUX
ajlm-1264	63	7	normalised	normalise	VERB
ajlm-1264	63	8	by	by	ADP
ajlm-1264	63	9	concentration	concentration	NOUN
ajlm-1264	63	10	,	,	PUNCT
ajlm-1264	63	11	using	use	VERB
ajlm-1264	63	12	the	the	DET
ajlm-1264	63	13	%	%	NOUN
ajlm-1264	63	14	difference	difference	NOUN
ajlm-1264	63	15	analysis	analysis	NOUN
ajlm-1264	63	16	(	(	PUNCT
ajlm-1264	63	17	figure	figure	NOUN
ajlm-1264	63	18	2b)9	2b)9	NUM
ajlm-1264	63	19	,	,	PUNCT
ajlm-1264	63	20	the	the	DET
ajlm-1264	63	21	correlation	correlation	NOUN
ajlm-1264	63	22	was	be	AUX
ajlm-1264	63	23	no	no	ADV
ajlm-1264	63	24	longer	long	ADV
ajlm-1264	63	25	significant	significant	ADJ
ajlm-1264	63	26	.	.	PUNCT
ajlm-1264	64	1	figure	figure	VERB
ajlm-1264	64	2	2	2	NUM
ajlm-1264	64	3	:	:	PUNCT
ajlm-1264	64	4	differences	difference	NOUN
ajlm-1264	64	5	in	in	ADP
ajlm-1264	64	6	nevirapine	nevirapine	ADJ
ajlm-1264	64	7	samples	sample	NOUN
ajlm-1264	64	8	(	(	PUNCT
ajlm-1264	64	9	n	n	NOUN
ajlm-1264	64	10	=	=	SYM
ajlm-1264	64	11	87	87	NUM
ajlm-1264	64	12	)	)	PUNCT
ajlm-1264	64	13	assayed	assayed	ADJ
ajlm-1264	64	14	at	at	ADP
ajlm-1264	64	15	unmc	unmc	NOUN
ajlm-1264	64	16	-	-	PUNCT
ajlm-1264	64	17	psl	psl	PROPN
ajlm-1264	64	18	(	(	PUNCT
ajlm-1264	64	19	omaha	omaha	PROPN
ajlm-1264	64	20	,	,	PUNCT
ajlm-1264	64	21	nebraska	nebraska	PROPN
ajlm-1264	64	22	,	,	PUNCT
ajlm-1264	64	23	united	united	PROPN
ajlm-1264	64	24	states	states	PROPN
ajlm-1264	64	25	,	,	PUNCT
ajlm-1264	64	26	october	october	PROPN
ajlm-1264	64	27	2017	2017	NUM
ajlm-1264	64	28	)	)	PUNCT
ajlm-1264	64	29	and	and	CCONJ
ajlm-1264	64	30	uz	uz	NOUN
ajlm-1264	64	31	-	-	PUNCT
ajlm-1264	64	32	ipsl	ipsl	PROPN
ajlm-1264	64	33	(	(	PUNCT
ajlm-1264	64	34	harare	harare	PROPN
ajlm-1264	64	35	,	,	PUNCT
ajlm-1264	64	36	zimbabwe	zimbabwe	PROPN
ajlm-1264	64	37	,	,	PUNCT
ajlm-1264	64	38	may	may	PROPN
ajlm-1264	64	39	2018	2018	NUM
ajlm-1264	64	40	)	)	PUNCT
ajlm-1264	64	41	.	.	PUNCT
ajlm-1264	65	1	(	(	PUNCT
ajlm-1264	65	2	a	a	X
ajlm-1264	65	3	)	)	PUNCT
ajlm-1264	65	4	bland	bland	ADJ
ajlm-1264	65	5	-	-	PUNCT
ajlm-1264	65	6	altman	altman	NOUN
ajlm-1264	65	7	difference	difference	NOUN
ajlm-1264	65	8	plot	plot	NOUN
ajlm-1264	65	9	indicating	indicate	VERB
ajlm-1264	65	10	proportionally	proportionally	ADV
ajlm-1264	65	11	higher	high	ADJ
ajlm-1264	65	12	difference	difference	NOUN
ajlm-1264	65	13	at	at	ADP
ajlm-1264	65	14	high	high	ADJ
ajlm-1264	65	15	concentrations	concentration	NOUN
ajlm-1264	65	16	(	(	PUNCT
ajlm-1264	65	17	mean	mean	INTJ
ajlm-1264	65	18	difference	difference	NOUN
ajlm-1264	65	19	=	=	SYM
ajlm-1264	65	20	−430	−430	NOUN
ajlm-1264	65	21	)	)	PUNCT
ajlm-1264	65	22	.	.	PUNCT
ajlm-1264	66	1	(	(	PUNCT
ajlm-1264	66	2	b	b	X
ajlm-1264	66	3	)	)	PUNCT
ajlm-1264	66	4	bland	bland	ADJ
ajlm-1264	66	5	-	-	PUNCT
ajlm-1264	66	6	altman	altman	NOUN
ajlm-1264	66	7	percentage	percentage	NOUN
ajlm-1264	66	8	difference	difference	NOUN
ajlm-1264	66	9	on	on	ADP
ajlm-1264	66	10	normalisation	normalisation	NOUN
ajlm-1264	66	11	by	by	ADP
ajlm-1264	66	12	concentration	concentration	NOUN
ajlm-1264	66	13	,	,	PUNCT
ajlm-1264	66	14	correlation	correlation	NOUN
ajlm-1264	66	15	not	not	PART
ajlm-1264	66	16	significant	significant	ADJ
ajlm-1264	66	17	(	(	PUNCT
ajlm-1264	66	18	mean	mean	ADJ
ajlm-1264	66	19	%	%	NOUN
ajlm-1264	66	20	deviation	deviation	NOUN
ajlm-1264	66	21	=	=	SYM
ajlm-1264	66	22	−4.49	−4.49	PROPN
ajlm-1264	66	23	)	)	PUNCT
ajlm-1264	66	24	.	.	PUNCT
ajlm-1264	67	1	shaded	shade	VERB
ajlm-1264	67	2	areas	area	NOUN
ajlm-1264	67	3	present	present	ADJ
ajlm-1264	67	4	confidence	confidence	NOUN
ajlm-1264	67	5	interval	interval	NOUN
ajlm-1264	67	6	limits	limit	NOUN
ajlm-1264	67	7	for	for	ADP
ajlm-1264	67	8	mean	mean	ADJ
ajlm-1264	67	9	(	(	PUNCT
ajlm-1264	67	10	green	green	ADJ
ajlm-1264	67	11	shade	shade	NOUN
ajlm-1264	67	12	)	)	PUNCT
ajlm-1264	67	13	and	and	CCONJ
ajlm-1264	67	14	agreement	agreement	NOUN
ajlm-1264	67	15	limits	limit	NOUN
ajlm-1264	67	16	(	(	PUNCT
ajlm-1264	67	17	red	red	ADJ
ajlm-1264	67	18	shade	shade	NOUN
ajlm-1264	67	19	)	)	PUNCT
ajlm-1264	67	20	.	.	PUNCT
ajlm-1264	68	1	discussion	discussion	NOUN
ajlm-1264	68	2	drug	drug	NOUN
ajlm-1264	68	3	concentrations	concentration	NOUN
ajlm-1264	68	4	for	for	ADP
ajlm-1264	68	5	nevirapine	nevirapine	ADJ
ajlm-1264	68	6	reported	report	VERB
ajlm-1264	68	7	in	in	ADP
ajlm-1264	68	8	the	the	DET
ajlm-1264	68	9	literature	literature	NOUN
ajlm-1264	68	10	for	for	ADP
ajlm-1264	68	11	hiv	hiv	PROPN
ajlm-1264	68	12	-	-	PUNCT
ajlm-1264	68	13	positive	positive	ADJ
ajlm-1264	68	14	individuals	individual	NOUN
ajlm-1264	68	15	indicate	indicate	VERB
ajlm-1264	68	16	a	a	DET
ajlm-1264	68	17	steady	steady	ADJ
ajlm-1264	68	18	state	state	NOUN
ajlm-1264	68	19	maximum	maximum	NOUN
ajlm-1264	68	20	of	of	ADP
ajlm-1264	68	21	5740	5740	NUM
ajlm-1264	68	22	ng	ng	PROPN
ajlm-1264	68	23	/	/	SYM
ajlm-1264	68	24	ml	ml	PROPN
ajlm-1264	68	25	(	(	PUNCT
ajlm-1264	68	26	5000–7440	5000–7440	NUM
ajlm-1264	68	27	)	)	PUNCT
ajlm-1264	68	28	and	and	CCONJ
ajlm-1264	68	29	minimum	minimum	NOUN
ajlm-1264	68	30	of	of	ADP
ajlm-1264	68	31	3730	3730	NUM
ajlm-1264	68	32	ng	ng	PROPN
ajlm-1264	68	33	/	/	SYM
ajlm-1264	68	34	ml	ml	PROPN
ajlm-1264	68	35	(	(	PUNCT
ajlm-1264	68	36	3200–5080)8	3200–5080)8	NUM
ajlm-1264	68	37	.	.	PUNCT
ajlm-1264	69	1	both	both	DET
ajlm-1264	69	2	nevirapine	nevirapine	ADJ
ajlm-1264	69	3	assays	assay	NOUN
ajlm-1264	69	4	from	from	ADP
ajlm-1264	69	5	the	the	DET
ajlm-1264	69	6	two	two	NUM
ajlm-1264	69	7	laboratories	laboratory	NOUN
ajlm-1264	69	8	can	can	AUX
ajlm-1264	69	9	detect	detect	VERB
ajlm-1264	69	10	concentrations	concentration	NOUN
ajlm-1264	69	11	that	that	PRON
ajlm-1264	69	12	might	might	AUX
ajlm-1264	69	13	be	be	AUX
ajlm-1264	69	14	below	below	ADP
ajlm-1264	69	15	the	the	DET
ajlm-1264	69	16	target	target	NOUN
ajlm-1264	69	17	concentration	concentration	NOUN
ajlm-1264	69	18	for	for	ADP
ajlm-1264	69	19	virologic	virologic	ADJ
ajlm-1264	69	20	suppression	suppression	NOUN
ajlm-1264	69	21	or	or	CCONJ
ajlm-1264	69	22	above	above	ADP
ajlm-1264	69	23	the	the	DET
ajlm-1264	69	24	upper	upper	ADJ
ajlm-1264	69	25	limit	limit	NOUN
ajlm-1264	69	26	of	of	ADP
ajlm-1264	69	27	the	the	DET
ajlm-1264	69	28	therapeutic	therapeutic	ADJ
ajlm-1264	69	29	range	range	NOUN
ajlm-1264	69	30	.	.	PUNCT
ajlm-1264	70	1	although	although	SCONJ
ajlm-1264	70	2	the	the	DET
ajlm-1264	70	3	uz	uz	NOUN
ajlm-1264	70	4	-	-	PUNCT
ajlm-1264	70	5	ipsl	ipsl	ADJ
ajlm-1264	70	6	nevirapine	nevirapine	ADJ
ajlm-1264	70	7	concentrations	concentration	NOUN
ajlm-1264	70	8	were	be	AUX
ajlm-1264	70	9	higher	high	ADJ
ajlm-1264	70	10	than	than	ADP
ajlm-1264	70	11	those	those	PRON
ajlm-1264	70	12	of	of	ADP
ajlm-1264	70	13	unmc	unmc	NOUN
ajlm-1264	70	14	-	-	PUNCT
ajlm-1264	70	15	psl	psl	PROPN
ajlm-1264	70	16	and	and	CCONJ
ajlm-1264	70	17	this	this	DET
ajlm-1264	70	18	difference	difference	NOUN
ajlm-1264	70	19	was	be	AUX
ajlm-1264	70	20	statistically	statistically	ADV
ajlm-1264	70	21	significant	significant	ADJ
ajlm-1264	70	22	,	,	PUNCT
ajlm-1264	70	23	it	it	PRON
ajlm-1264	70	24	is	be	AUX
ajlm-1264	70	25	unlikely	unlikely	ADJ
ajlm-1264	70	26	to	to	PART
ajlm-1264	70	27	have	have	VERB
ajlm-1264	70	28	clinical	clinical	ADJ
ajlm-1264	70	29	significance	significance	NOUN
ajlm-1264	70	30	.	.	PUNCT
ajlm-1264	71	1	the	the	DET
ajlm-1264	71	2	united	united	PROPN
ajlm-1264	71	3	states	states	PROPN
ajlm-1264	71	4	food	food	PROPN
ajlm-1264	71	5	and	and	CCONJ
ajlm-1264	71	6	drug	drug	NOUN
ajlm-1264	71	7	administration	administration	NOUN
ajlm-1264	71	8	does	do	AUX
ajlm-1264	71	9	not	not	PART
ajlm-1264	71	10	provide	provide	VERB
ajlm-1264	71	11	a	a	DET
ajlm-1264	71	12	window	window	NOUN
ajlm-1264	71	13	of	of	ADP
ajlm-1264	71	14	acceptance	acceptance	NOUN
ajlm-1264	71	15	for	for	ADP
ajlm-1264	71	16	cross	cross	ADJ
ajlm-1264	71	17	-	-	ADJ
ajlm-1264	71	18	validation	validation	ADJ
ajlm-1264	71	19	studies	study	NOUN
ajlm-1264	71	20	but	but	CCONJ
ajlm-1264	71	21	allows	allow	VERB
ajlm-1264	71	22	laboratories	laboratory	NOUN
ajlm-1264	71	23	to	to	PART
ajlm-1264	71	24	determine	determine	VERB
ajlm-1264	71	25	a	a	DET
ajlm-1264	71	26	priori	priori	ADV
ajlm-1264	71	27	the	the	DET
ajlm-1264	71	28	acceptance	acceptance	NOUN
ajlm-1264	71	29	criteria	criterion	NOUN
ajlm-1264	71	30	.	.	PUNCT
ajlm-1264	72	1	using	use	VERB
ajlm-1264	72	2	the	the	DET
ajlm-1264	72	3	established	establish	VERB
ajlm-1264	72	4	acceptance	acceptance	NOUN
ajlm-1264	72	5	window	window	NOUN
ajlm-1264	72	6	for	for	ADP
ajlm-1264	72	7	clinical	clinical	ADJ
ajlm-1264	72	8	pharmacology	pharmacology	NOUN
ajlm-1264	72	9	quality	quality	NOUN
ajlm-1264	72	10	assurance	assurance	NOUN
ajlm-1264	72	11	pt	pt	NOUN
ajlm-1264	72	12	samples	sample	NOUN
ajlm-1264	72	13	,	,	PUNCT
ajlm-1264	72	14	about	about	ADV
ajlm-1264	72	15	20	20	NUM
ajlm-1264	72	16	%	%	NOUN
ajlm-1264	72	17	of	of	ADP
ajlm-1264	72	18	the	the	DET
ajlm-1264	72	19	final	final	ADJ
ajlm-1264	72	20	target	target	NOUN
ajlm-1264	72	21	value	value	NOUN
ajlm-1264	72	22	,	,	PUNCT
ajlm-1264	72	23	and	and	CCONJ
ajlm-1264	72	24	expected	expect	VERB
ajlm-1264	72	25	concentrations	concentration	NOUN
ajlm-1264	72	26	of	of	ADP
ajlm-1264	72	27	nevirapine	nevirapine	ADJ
ajlm-1264	72	28	,	,	PUNCT
ajlm-1264	72	29	this	this	DET
ajlm-1264	72	30	difference	difference	NOUN
ajlm-1264	72	31	was	be	AUX
ajlm-1264	72	32	acceptable	acceptable	ADJ
ajlm-1264	72	33	.	.	PUNCT
ajlm-1264	73	1	the	the	DET
ajlm-1264	73	2	outcomes	outcome	NOUN
ajlm-1264	73	3	of	of	ADP
ajlm-1264	73	4	the	the	DET
ajlm-1264	73	5	cross	cross	NOUN
ajlm-1264	73	6	-	-	NOUN
ajlm-1264	73	7	validation	validation	NOUN
ajlm-1264	73	8	also	also	ADV
ajlm-1264	73	9	presented	present	VERB
ajlm-1264	73	10	an	an	DET
ajlm-1264	73	11	opportunity	opportunity	NOUN
ajlm-1264	73	12	to	to	PART
ajlm-1264	73	13	perform	perform	VERB
ajlm-1264	73	14	a	a	DET
ajlm-1264	73	15	root	root	NOUN
ajlm-1264	73	16	-	-	PUNCT
ajlm-1264	73	17	cause	cause	NOUN
ajlm-1264	73	18	analysis	analysis	NOUN
ajlm-1264	73	19	.	.	PUNCT
ajlm-1264	74	1	the	the	DET
ajlm-1264	74	2	uz	uz	PROPN
ajlm-1264	74	3	-	-	PUNCT
ajlm-1264	74	4	ipsl	ipsl	PROPN
ajlm-1264	74	5	’s	’s	PART
ajlm-1264	74	6	trend	trend	NOUN
ajlm-1264	74	7	of	of	ADP
ajlm-1264	74	8	pt	pt	NOUN
ajlm-1264	74	9	outcomes	outcome	NOUN
ajlm-1264	74	10	before	before	ADP
ajlm-1264	74	11	and	and	CCONJ
ajlm-1264	74	12	during	during	ADP
ajlm-1264	74	13	the	the	DET
ajlm-1264	74	14	a5279	a5279	PROPN
ajlm-1264	74	15	sample	sample	NOUN
ajlm-1264	74	16	analysis	analysis	NOUN
ajlm-1264	74	17	period	period	NOUN
ajlm-1264	74	18	was	be	AUX
ajlm-1264	74	19	explored	explore	VERB
ajlm-1264	74	20	.	.	PUNCT
ajlm-1264	75	1	while	while	SCONJ
ajlm-1264	75	2	all	all	DET
ajlm-1264	75	3	pt	pt	NOUN
ajlm-1264	75	4	results	result	NOUN
ajlm-1264	75	5	were	be	AUX
ajlm-1264	75	6	satisfactory	satisfactory	ADJ
ajlm-1264	75	7	,	,	PUNCT
ajlm-1264	75	8	agreement	agreement	NOUN
ajlm-1264	75	9	of	of	ADP
ajlm-1264	75	10	initial	initial	ADJ
ajlm-1264	75	11	pt	pt	NOUN
ajlm-1264	75	12	sample	sample	NOUN
ajlm-1264	75	13	analyses	analysis	NOUN
ajlm-1264	75	14	showed	show	VERB
ajlm-1264	75	15	unbiased	unbiased	ADJ
ajlm-1264	75	16	accuracy	accuracy	NOUN
ajlm-1264	75	17	,	,	PUNCT
ajlm-1264	75	18	while	while	SCONJ
ajlm-1264	75	19	during	during	ADP
ajlm-1264	75	20	subsequent	subsequent	ADJ
ajlm-1264	75	21	analyses	analysis	NOUN
ajlm-1264	75	22	which	which	PRON
ajlm-1264	75	23	coincided	coincide	VERB
ajlm-1264	75	24	with	with	ADP
ajlm-1264	75	25	a5279	a5279	PROPN
ajlm-1264	75	26	sample	sample	NOUN
ajlm-1264	75	27	analysis	analysis	NOUN
ajlm-1264	75	28	,	,	PUNCT
ajlm-1264	75	29	the	the	DET
ajlm-1264	75	30	uz	uz	NOUN
ajlm-1264	75	31	-	-	PUNCT
ajlm-1264	75	32	ipsl	ipsl	ADJ
ajlm-1264	75	33	values	value	NOUN
ajlm-1264	75	34	exhibited	exhibit	VERB
ajlm-1264	75	35	a	a	DET
ajlm-1264	75	36	biased	biased	ADJ
ajlm-1264	75	37	,	,	PUNCT
ajlm-1264	75	38	high	high	ADJ
ajlm-1264	75	39	trend	trend	NOUN
ajlm-1264	75	40	(	(	PUNCT
ajlm-1264	75	41	4	4	NUM
ajlm-1264	75	42	%	%	NOUN
ajlm-1264	75	43	–	–	PUNCT
ajlm-1264	75	44	19	19	NUM
ajlm-1264	75	45	%	%	NOUN
ajlm-1264	75	46	)	)	PUNCT
ajlm-1264	75	47	as	as	SCONJ
ajlm-1264	75	48	compared	compare	VERB
ajlm-1264	75	49	to	to	ADP
ajlm-1264	75	50	the	the	DET
ajlm-1264	75	51	final	final	ADJ
ajlm-1264	75	52	target	target	NOUN
ajlm-1264	75	53	values	value	NOUN
ajlm-1264	75	54	of	of	ADP
ajlm-1264	75	55	that	that	DET
ajlm-1264	75	56	pt	pt	NOUN
ajlm-1264	75	57	round	round	NOUN
ajlm-1264	75	58	.	.	PUNCT
ajlm-1264	76	1	this	this	DET
ajlm-1264	76	2	shift	shift	NOUN
ajlm-1264	76	3	in	in	ADP
ajlm-1264	76	4	bias	bias	NOUN
ajlm-1264	76	5	and	and	CCONJ
ajlm-1264	76	6	accuracy	accuracy	NOUN
ajlm-1264	76	7	was	be	AUX
ajlm-1264	76	8	provided	provide	VERB
ajlm-1264	76	9	within	within	ADP
ajlm-1264	76	10	the	the	DET
ajlm-1264	76	11	pt	pt	NOUN
ajlm-1264	76	12	report	report	NOUN
ajlm-1264	76	13	and	and	CCONJ
ajlm-1264	76	14	the	the	DET
ajlm-1264	76	15	uz	uz	PROPN
ajlm-1264	76	16	-	-	PUNCT
ajlm-1264	76	17	ipsl	ipsl	PROPN
ajlm-1264	76	18	was	be	AUX
ajlm-1264	76	19	able	able	ADJ
ajlm-1264	76	20	to	to	PART
ajlm-1264	76	21	complete	complete	VERB
ajlm-1264	76	22	a	a	DET
ajlm-1264	76	23	root	root	NOUN
ajlm-1264	76	24	-	-	PUNCT
ajlm-1264	76	25	cause	cause	NOUN
ajlm-1264	76	26	analysis	analysis	NOUN
ajlm-1264	76	27	and	and	CCONJ
ajlm-1264	76	28	remediate	remediate	VERB
ajlm-1264	76	29	as	as	SCONJ
ajlm-1264	76	30	needed	need	VERB
ajlm-1264	76	31	.	.	PUNCT
ajlm-1264	77	1	limitations	limitation	NOUN
ajlm-1264	77	2	one	one	NUM
ajlm-1264	77	3	limitation	limitation	NOUN
ajlm-1264	77	4	to	to	PART
ajlm-1264	77	5	consider	consider	VERB
ajlm-1264	77	6	is	be	AUX
ajlm-1264	77	7	that	that	SCONJ
ajlm-1264	77	8	the	the	DET
ajlm-1264	77	9	calibration	calibration	NOUN
ajlm-1264	77	10	ranges	range	VERB
ajlm-1264	77	11	for	for	SCONJ
ajlm-1264	77	12	the	the	DET
ajlm-1264	77	13	two	two	NUM
ajlm-1264	77	14	equipment	equipment	NOUN
ajlm-1264	77	15	sets	set	NOUN
ajlm-1264	77	16	used	use	VERB
ajlm-1264	77	17	for	for	ADP
ajlm-1264	77	18	the	the	DET
ajlm-1264	77	19	nevirapine	nevirapine	ADJ
ajlm-1264	77	20	analysis	analysis	NOUN
ajlm-1264	77	21	were	be	AUX
ajlm-1264	77	22	not	not	PART
ajlm-1264	77	23	identical	identical	ADJ
ajlm-1264	77	24	.	.	PUNCT
ajlm-1264	78	1	future	future	ADJ
ajlm-1264	78	2	comparisons	comparison	NOUN
ajlm-1264	78	3	of	of	ADP
ajlm-1264	78	4	this	this	DET
ajlm-1264	78	5	nature	nature	NOUN
ajlm-1264	78	6	may	may	AUX
ajlm-1264	78	7	benefit	benefit	VERB
ajlm-1264	78	8	from	from	ADP
ajlm-1264	78	9	evaluations	evaluation	NOUN
ajlm-1264	78	10	where	where	SCONJ
ajlm-1264	78	11	the	the	DET
ajlm-1264	78	12	calibration	calibration	NOUN
ajlm-1264	78	13	range	range	NOUN
ajlm-1264	78	14	is	be	AUX
ajlm-1264	78	15	the	the	DET
ajlm-1264	78	16	same	same	ADJ
ajlm-1264	78	17	for	for	ADP
ajlm-1264	78	18	both	both	DET
ajlm-1264	78	19	laboratories	laboratory	NOUN
ajlm-1264	78	20	.	.	PUNCT
ajlm-1264	79	1	in	in	ADP
ajlm-1264	79	2	addition	addition	NOUN
ajlm-1264	79	3	,	,	PUNCT
ajlm-1264	79	4	limited	limited	ADJ
ajlm-1264	79	5	data	datum	NOUN
ajlm-1264	79	6	points	point	NOUN
ajlm-1264	79	7	above	above	ADP
ajlm-1264	79	8	20	20	NUM
ajlm-1264	79	9	000	000	NUM
ajlm-1264	79	10	ng	ng	PROPN
ajlm-1264	79	11	/	/	SYM
ajlm-1264	79	12	ml	ml	VERB
ajlm-1264	79	13	entailed	entail	VERB
ajlm-1264	79	14	difficulties	difficulty	NOUN
ajlm-1264	79	15	in	in	ADP
ajlm-1264	79	16	quantitation	quantitation	NOUN
ajlm-1264	79	17	of	of	ADP
ajlm-1264	79	18	proportional	proportional	ADJ
ajlm-1264	79	19	error	error	NOUN
ajlm-1264	79	20	at	at	ADP
ajlm-1264	79	21	that	that	DET
ajlm-1264	79	22	level	level	NOUN
ajlm-1264	79	23	.	.	PUNCT
ajlm-1264	80	1	conclusion	conclusion	NOUN
ajlm-1264	80	2	the	the	DET
ajlm-1264	80	3	cross	cross	ADJ
ajlm-1264	80	4	-	-	ADJ
ajlm-1264	80	5	validation	validation	ADJ
ajlm-1264	80	6	study	study	NOUN
ajlm-1264	80	7	provided	provide	VERB
ajlm-1264	80	8	evidence	evidence	NOUN
ajlm-1264	80	9	that	that	SCONJ
ajlm-1264	80	10	the	the	DET
ajlm-1264	80	11	uz	uz	NOUN
ajlm-1264	80	12	-	-	PUNCT
ajlm-1264	80	13	ipsl	ipsl	ADJ
ajlm-1264	80	14	performance	performance	NOUN
ajlm-1264	80	15	using	use	VERB
ajlm-1264	80	16	a	a	DET
ajlm-1264	80	17	nevirapine	nevirapine	ADJ
ajlm-1264	80	18	assay	assay	NOUN
ajlm-1264	80	19	that	that	PRON
ajlm-1264	80	20	was	be	AUX
ajlm-1264	80	21	validated	validate	VERB
ajlm-1264	80	22	in	in	ADP
ajlm-1264	80	23	their	their	PRON
ajlm-1264	80	24	laboratory	laboratory	NOUN
ajlm-1264	80	25	was	be	AUX
ajlm-1264	80	26	acceptable	acceptable	ADJ
ajlm-1264	80	27	and	and	CCONJ
ajlm-1264	80	28	correlated	correlate	VERB
ajlm-1264	80	29	with	with	ADP
ajlm-1264	80	30	the	the	DET
ajlm-1264	80	31	results	result	NOUN
ajlm-1264	80	32	of	of	ADP
ajlm-1264	80	33	an	an	DET
ajlm-1264	80	34	experienced	experienced	ADJ
ajlm-1264	80	35	psl	psl	NOUN
ajlm-1264	80	36	.	.	PUNCT
ajlm-1264	81	1	this	this	DET
ajlm-1264	81	2	study	study	NOUN
ajlm-1264	81	3	afforded	afford	VERB
ajlm-1264	81	4	the	the	DET
ajlm-1264	81	5	uz	uz	NOUN
ajlm-1264	81	6	-	-	PUNCT
ajlm-1264	81	7	ipsl	ipsl	PROPN
ajlm-1264	81	8	a	a	DET
ajlm-1264	81	9	valuable	valuable	ADJ
ajlm-1264	81	10	opportunity	opportunity	NOUN
ajlm-1264	81	11	to	to	PART
ajlm-1264	81	12	implement	implement	VERB
ajlm-1264	81	13	operations	operation	NOUN
ajlm-1264	81	14	using	use	VERB
ajlm-1264	81	15	its	its	PRON
ajlm-1264	81	16	validated	validate	VERB
ajlm-1264	81	17	nevirapine	nevirapine	ADJ
ajlm-1264	81	18	assay	assay	NOUN
ajlm-1264	81	19	for	for	ADP
ajlm-1264	81	20	the	the	DET
ajlm-1264	81	21	analysis	analysis	NOUN
ajlm-1264	81	22	of	of	ADP
ajlm-1264	81	23	samples	sample	NOUN
ajlm-1264	81	24	obtained	obtain	VERB
ajlm-1264	81	25	from	from	ADP
ajlm-1264	81	26	a	a	DET
ajlm-1264	81	27	clinical	clinical	ADJ
ajlm-1264	81	28	research	research	NOUN
ajlm-1264	81	29	protocol	protocol	NOUN
ajlm-1264	81	30	and	and	CCONJ
ajlm-1264	81	31	adopt	adopt	VERB
ajlm-1264	81	32	procedures	procedure	NOUN
ajlm-1264	81	33	for	for	ADP
ajlm-1264	81	34	handling	handling	NOUN
ajlm-1264	81	35	of	of	ADP
ajlm-1264	81	36	protocol	protocol	NOUN
ajlm-1264	81	37	specimens	specimen	NOUN
ajlm-1264	81	38	based	base	VERB
ajlm-1264	81	39	on	on	ADP
ajlm-1264	81	40	experience	experience	NOUN
ajlm-1264	81	41	.	.	PUNCT
ajlm-1264	82	1	furthermore	furthermore	ADV
ajlm-1264	82	2	,	,	PUNCT
ajlm-1264	82	3	the	the	DET
ajlm-1264	82	4	outcomes	outcome	NOUN
ajlm-1264	82	5	of	of	ADP
ajlm-1264	82	6	the	the	DET
ajlm-1264	82	7	cross	cross	ADJ
ajlm-1264	82	8	-	-	ADJ
ajlm-1264	82	9	validation	validation	NOUN
ajlm-1264	82	10	emphasised	emphasise	VERB
ajlm-1264	82	11	the	the	DET
ajlm-1264	82	12	value	value	NOUN
ajlm-1264	82	13	of	of	ADP
ajlm-1264	82	14	pt	pt	NOUN
ajlm-1264	82	15	and	and	CCONJ
ajlm-1264	82	16	provided	provide	VERB
ajlm-1264	82	17	an	an	DET
ajlm-1264	82	18	occasion	occasion	NOUN
ajlm-1264	82	19	to	to	PART
ajlm-1264	82	20	perform	perform	VERB
ajlm-1264	82	21	root	root	NOUN
ajlm-1264	82	22	-	-	PUNCT
ajlm-1264	82	23	cause	cause	NOUN
ajlm-1264	82	24	analysis	analysis	NOUN
ajlm-1264	82	25	.	.	PUNCT
ajlm-1264	83	1	acknowledgements	acknowledgement	NOUN
ajlm-1264	83	2	the	the	DET
ajlm-1264	83	3	uz	uz	PROPN
ajlm-1264	83	4	-	-	PUNCT
ajlm-1264	83	5	ipsl	ipsl	PROPN
ajlm-1264	83	6	acknowledges	acknowledge	VERB
ajlm-1264	83	7	the	the	DET
ajlm-1264	83	8	contribution	contribution	NOUN
ajlm-1264	83	9	of	of	ADP
ajlm-1264	83	10	dr	dr	PROPN
ajlm-1264	83	11	marshall	marshall	PROPN
ajlm-1264	83	12	munjoma	munjoma	PROPN
ajlm-1264	83	13	for	for	ADP
ajlm-1264	83	14	his	his	PRON
ajlm-1264	83	15	support	support	NOUN
ajlm-1264	83	16	during	during	ADP
ajlm-1264	83	17	the	the	DET
ajlm-1264	83	18	laboratory	laboratory	NOUN
ajlm-1264	83	19	work	work	NOUN
ajlm-1264	83	20	that	that	PRON
ajlm-1264	83	21	led	lead	VERB
ajlm-1264	83	22	to	to	ADP
ajlm-1264	83	23	the	the	DET
ajlm-1264	83	24	development	development	NOUN
ajlm-1264	83	25	of	of	ADP
ajlm-1264	83	26	this	this	DET
ajlm-1264	83	27	manuscript	manuscript	NOUN
ajlm-1264	83	28	.	.	PUNCT
ajlm-1264	84	1	competing	compete	VERB
ajlm-1264	84	2	interests	interest	NOUN
ajlm-1264	84	3	the	the	DET
ajlm-1264	84	4	authors	author	NOUN
ajlm-1264	84	5	declare	declare	VERB
ajlm-1264	84	6	that	that	SCONJ
ajlm-1264	84	7	they	they	PRON
ajlm-1264	84	8	have	have	VERB
ajlm-1264	84	9	no	no	DET
ajlm-1264	84	10	financial	financial	ADJ
ajlm-1264	84	11	or	or	CCONJ
ajlm-1264	84	12	personal	personal	ADJ
ajlm-1264	84	13	relationships	relationship	NOUN
ajlm-1264	84	14	that	that	PRON
ajlm-1264	84	15	may	may	AUX
ajlm-1264	84	16	have	have	AUX
ajlm-1264	84	17	inappropriately	inappropriately	ADV
ajlm-1264	84	18	influenced	influence	VERB
ajlm-1264	84	19	them	they	PRON
ajlm-1264	84	20	in	in	ADP
ajlm-1264	84	21	writing	write	VERB
ajlm-1264	84	22	this	this	DET
ajlm-1264	84	23	article	article	NOUN
ajlm-1264	84	24	.	.	PUNCT
ajlm-1264	85	1	authors	author	NOUN
ajlm-1264	85	2	’	’	PART
ajlm-1264	85	3	contributions	contribution	NOUN
ajlm-1264	85	4	f.m.-c	f.m.-c	NOUN
ajlm-1264	85	5	.	.	PUNCT
ajlm-1264	85	6	was	be	AUX
ajlm-1264	85	7	the	the	DET
ajlm-1264	85	8	project	project	NOUN
ajlm-1264	85	9	leader	leader	NOUN
ajlm-1264	85	10	and	and	CCONJ
ajlm-1264	85	11	f.m	f.m	PROPN
ajlm-1264	85	12	.	.	PROPN
ajlm-1264	85	13	was	be	AUX
ajlm-1264	85	14	the	the	DET
ajlm-1264	85	15	laboratory	laboratory	NOUN
ajlm-1264	85	16	technologist	technologist	NOUN
ajlm-1264	85	17	.	.	PUNCT
ajlm-1264	86	1	t.mudzviti	t.mudzviti	PROPN
ajlm-1264	86	2	and	and	CCONJ
ajlm-1264	86	3	c.c.m	c.c.m	PROPN
ajlm-1264	86	4	.	.	PROPN
ajlm-1264	86	5	provided	provide	VERB
ajlm-1264	86	6	manuscript	manuscript	NOUN
ajlm-1264	86	7	review	review	NOUN
ajlm-1264	86	8	and	and	CCONJ
ajlm-1264	86	9	supervised	supervise	VERB
ajlm-1264	86	10	the	the	DET
ajlm-1264	86	11	uz	uz	NOUN
ajlm-1264	86	12	-	-	PUNCT
ajlm-1264	86	13	ipsl	ipsl	ADJ
ajlm-1264	86	14	activities	activity	NOUN
ajlm-1264	86	15	for	for	ADP
ajlm-1264	86	16	the	the	DET
ajlm-1264	86	17	project	project	NOUN
ajlm-1264	86	18	.	.	PUNCT
ajlm-1264	87	1	a.t.p	a.t.p	NOUN
ajlm-1264	87	2	.	.	PUNCT
ajlm-1264	88	1	was	be	AUX
ajlm-1264	88	2	clinical	clinical	ADJ
ajlm-1264	88	3	pharmacologist	pharmacologist	NOUN
ajlm-1264	88	4	and	and	CCONJ
ajlm-1264	88	5	c.v.f	c.v.f	PROPN
ajlm-1264	88	6	.	.	PROPN
ajlm-1264	88	7	was	be	AUX
ajlm-1264	88	8	the	the	DET
ajlm-1264	88	9	psl	psl	PROPN
ajlm-1264	88	10	director	director	NOUN
ajlm-1264	88	11	and	and	CCONJ
ajlm-1264	88	12	a5279	a5279	PROPN
ajlm-1264	88	13	pharmacology	pharmacology	NOUN
ajlm-1264	88	14	investigator	investigator	NOUN
ajlm-1264	88	15	.	.	PUNCT
ajlm-1264	89	1	t.mykris	t.mykris	PROPN
ajlm-1264	89	2	and	and	CCONJ
ajlm-1264	89	3	l.c.w	l.c.w	PROPN
ajlm-1264	89	4	.	.	PROPN
ajlm-1264	89	5	were	be	AUX
ajlm-1264	89	6	laboratory	laboratory	NOUN
ajlm-1264	89	7	technologists	technologist	NOUN
ajlm-1264	89	8	.	.	PUNCT
ajlm-1264	90	1	a.j.o	a.j.o	PROPN
ajlm-1264	90	2	.	.	PROPN
ajlm-1264	90	3	,	,	PUNCT
ajlm-1264	90	4	r.w.b	r.w.b	PROPN
ajlm-1264	90	5	.	.	PROPN
ajlm-1264	90	6	,	,	PUNCT
ajlm-1264	90	7	r.d	r.d	PROPN
ajlm-1264	90	8	.	.	PROPN
ajlm-1264	90	9	and	and	CCONJ
ajlm-1264	90	10	g.d.m	g.d.m	PROPN
ajlm-1264	90	11	.	.	PUNCT
ajlm-1264	90	12	provided	provide	VERB
ajlm-1264	90	13	clinical	clinical	ADJ
ajlm-1264	90	14	pharmacology	pharmacology	NOUN
ajlm-1264	90	15	quality	quality	NOUN
ajlm-1264	90	16	assurance	assurance	NOUN
ajlm-1264	90	17	project	project	NOUN
ajlm-1264	90	18	design	design	NOUN
ajlm-1264	90	19	and	and	CCONJ
ajlm-1264	90	20	data	datum	NOUN
ajlm-1264	90	21	analysis	analysis	NOUN
ajlm-1264	90	22	.	.	PUNCT
ajlm-1264	91	1	all	all	DET
ajlm-1264	91	2	authors	author	NOUN
ajlm-1264	91	3	critically	critically	ADV
ajlm-1264	91	4	revised	revise	VERB
ajlm-1264	91	5	intellectual	intellectual	ADJ
ajlm-1264	91	6	content	content	NOUN
ajlm-1264	91	7	and	and	CCONJ
ajlm-1264	91	8	approved	approve	VERB
ajlm-1264	91	9	the	the	DET
ajlm-1264	91	10	final	final	ADJ
ajlm-1264	91	11	version	version	NOUN
ajlm-1264	91	12	to	to	PART
ajlm-1264	91	13	be	be	AUX
ajlm-1264	91	14	published	publish	VERB
ajlm-1264	91	15	.	.	PUNCT
ajlm-1264	92	1	sources	source	NOUN
ajlm-1264	92	2	of	of	ADP
ajlm-1264	92	3	support	support	NOUN
ajlm-1264	92	4	university	university	PROPN
ajlm-1264	92	5	of	of	ADP
ajlm-1264	92	6	zimbabwe	zimbabwe	PROPN
ajlm-1264	92	7	ipsl	ipsl	NOUN
ajlm-1264	92	8	:	:	PUNCT
ajlm-1264	92	9	project	project	NOUN
ajlm-1264	92	10	was	be	AUX
ajlm-1264	92	11	funded	fund	VERB
ajlm-1264	92	12	by	by	ADP
ajlm-1264	92	13	the	the	DET
ajlm-1264	92	14	united	united	PROPN
ajlm-1264	92	15	states	states	PROPN
ajlm-1264	92	16	national	national	PROPN
ajlm-1264	92	17	institute	institute	PROPN
ajlm-1264	92	18	of	of	ADP
ajlm-1264	92	19	allergy	allergy	PROPN
ajlm-1264	92	20	and	and	CCONJ
ajlm-1264	92	21	infectious	infectious	ADJ
ajlm-1264	92	22	diseases	disease	NOUN
ajlm-1264	92	23	,	,	PUNCT
ajlm-1264	92	24	national	national	ADJ
ajlm-1264	92	25	institutes	institutes	PROPN
ajlm-1264	92	26	of	of	ADP
ajlm-1264	92	27	health	health	PROPN
ajlm-1264	92	28	(	(	PUNCT
ajlm-1264	92	29	aids	aids	PROPN
ajlm-1264	92	30	clinical	clinical	ADJ
ajlm-1264	92	31	trials	trial	NOUN
ajlm-1264	92	32	group	group	NOUN
ajlm-1264	92	33	grant	grant	VERB
ajlm-1264	92	34	5um1ai106701	5um1ai106701	PROPN
ajlm-1264	92	35	-	-	PUNCT
ajlm-1264	92	36	04	04	NUM
ajlm-1264	92	37	)	)	PUNCT
ajlm-1264	92	38	.	.	PUNCT
ajlm-1264	93	1	university	university	PROPN
ajlm-1264	93	2	of	of	ADP
ajlm-1264	93	3	nebraska	nebraska	PROPN
ajlm-1264	93	4	psl	psl	PROPN
ajlm-1264	93	5	:	:	PUNCT
ajlm-1264	93	6	project	project	NOUN
ajlm-1264	93	7	was	be	AUX
ajlm-1264	93	8	funded	fund	VERB
ajlm-1264	93	9	by	by	ADP
ajlm-1264	93	10	the	the	DET
ajlm-1264	93	11	united	united	PROPN
ajlm-1264	93	12	states	states	PROPN
ajlm-1264	93	13	national	national	PROPN
ajlm-1264	93	14	institute	institute	PROPN
ajlm-1264	93	15	of	of	ADP
ajlm-1264	93	16	allergy	allergy	PROPN
ajlm-1264	93	17	and	and	CCONJ
ajlm-1264	93	18	infectious	infectious	ADJ
ajlm-1264	93	19	diseases	disease	NOUN
ajlm-1264	93	20	,	,	PUNCT
ajlm-1264	93	21	national	national	ADJ
ajlm-1264	93	22	institutes	institutes	PROPN
ajlm-1264	93	23	of	of	ADP
ajlm-1264	93	24	health	health	NOUN
ajlm-1264	93	25	,	,	PUNCT
ajlm-1264	93	26	department	department	NOUN
ajlm-1264	93	27	of	of	ADP
ajlm-1264	93	28	health	health	PROPN
ajlm-1264	93	29	and	and	CCONJ
ajlm-1264	93	30	human	human	PROPN
ajlm-1264	93	31	services	service	NOUN
ajlm-1264	93	32	awards	awards	PROPN
ajlm-1264	93	33	atp	atp	PROPN
ajlm-1264	93	34	(	(	PUNCT
ajlm-1264	93	35	k23	k23	PROPN
ajlm-1264	93	36	ai134307	ai134307	PROPN
ajlm-1264	93	37	)	)	PUNCT
ajlm-1264	93	38	,	,	PUNCT
ajlm-1264	93	39	and	and	CCONJ
ajlm-1264	93	40	cvf	cvf	NOUN
ajlm-1264	93	41	(	(	PUNCT
ajlm-1264	93	42	um	um	INTJ
ajlm-1264	93	43	ai106701	ai106701	NOUN
ajlm-1264	93	44	)	)	PUNCT
ajlm-1264	93	45	.	.	PUNCT
ajlm-1264	94	1	clinical	clinical	ADJ
ajlm-1264	94	2	pharmacology	pharmacology	NOUN
ajlm-1264	94	3	quality	quality	NOUN
ajlm-1264	94	4	assurance	assurance	NOUN
ajlm-1264	94	5	program	program	NOUN
ajlm-1264	94	6	:	:	PUNCT
ajlm-1264	94	7	this	this	DET
ajlm-1264	94	8	project	project	NOUN
ajlm-1264	94	9	has	have	AUX
ajlm-1264	94	10	been	be	AUX
ajlm-1264	94	11	funded	fund	VERB
ajlm-1264	94	12	in	in	ADP
ajlm-1264	94	13	whole	whole	ADJ
ajlm-1264	94	14	or	or	CCONJ
ajlm-1264	94	15	in	in	ADP
ajlm-1264	94	16	part	part	NOUN
ajlm-1264	94	17	with	with	ADP
ajlm-1264	94	18	federal	federal	ADJ
ajlm-1264	94	19	funds	fund	NOUN
ajlm-1264	94	20	from	from	ADP
ajlm-1264	94	21	the	the	DET
ajlm-1264	94	22	united	united	PROPN
ajlm-1264	94	23	states	states	PROPN
ajlm-1264	94	24	national	national	PROPN
ajlm-1264	94	25	institute	institute	PROPN
ajlm-1264	94	26	of	of	ADP
ajlm-1264	94	27	allergy	allergy	PROPN
ajlm-1264	94	28	and	and	CCONJ
ajlm-1264	94	29	infectious	infectious	ADJ
ajlm-1264	94	30	diseases	disease	NOUN
ajlm-1264	94	31	,	,	PUNCT
ajlm-1264	94	32	national	national	ADJ
ajlm-1264	94	33	institutes	institutes	PROPN
ajlm-1264	94	34	of	of	ADP
ajlm-1264	94	35	health	health	PROPN
ajlm-1264	94	36	and	and	CCONJ
ajlm-1264	94	37	the	the	DET
ajlm-1264	94	38	department	department	NOUN
ajlm-1264	94	39	of	of	ADP
ajlm-1264	94	40	health	health	PROPN
ajlm-1264	94	41	and	and	CCONJ
ajlm-1264	94	42	human	human	ADJ
ajlm-1264	94	43	services	service	NOUN
ajlm-1264	94	44	,	,	PUNCT
ajlm-1264	94	45	under	under	ADP
ajlm-1264	94	46	contract	contract	NOUN
ajlm-1264	94	47	numbers	number	NOUN
ajlm-1264	94	48	hhsn272201500006c	hhsn272201500006c	PROPN
ajlm-1264	94	49	and	and	CCONJ
ajlm-1264	94	50	hhsn272200800019c	hhsn272200800019c	PROPN
ajlm-1264	94	51	.	.	PUNCT
ajlm-1264	95	1	center	center	NOUN
ajlm-1264	95	2	for	for	ADP
ajlm-1264	95	3	aids	aids	PROPN
ajlm-1264	95	4	research	research	NOUN
ajlm-1264	95	5	:	:	PUNCT
ajlm-1264	95	6	this	this	DET
ajlm-1264	95	7	publication	publication	NOUN
ajlm-1264	95	8	was	be	AUX
ajlm-1264	95	9	made	make	VERB
ajlm-1264	95	10	possible	possible	ADJ
ajlm-1264	95	11	through	through	ADP
ajlm-1264	95	12	core	core	NOUN
ajlm-1264	95	13	services	service	NOUN
ajlm-1264	95	14	and	and	CCONJ
ajlm-1264	95	15	support	support	NOUN
ajlm-1264	95	16	from	from	ADP
ajlm-1264	95	17	the	the	DET
ajlm-1264	95	18	university	university	PROPN
ajlm-1264	95	19	of	of	ADP
ajlm-1264	95	20	rochester	rochester	PROPN
ajlm-1264	95	21	center	center	PROPN
ajlm-1264	95	22	for	for	ADP
ajlm-1264	95	23	aids	aids	PROPN
ajlm-1264	95	24	research	research	NOUN
ajlm-1264	95	25	,	,	PUNCT
ajlm-1264	95	26	a	a	DET
ajlm-1264	95	27	united	united	PROPN
ajlm-1264	95	28	states	states	PROPN
ajlm-1264	95	29	national	national	PROPN
ajlm-1264	95	30	institutes	institutes	PROPN
ajlm-1264	95	31	of	of	ADP
ajlm-1264	95	32	health	health	NOUN
ajlm-1264	95	33	-	-	PUNCT
ajlm-1264	95	34	funded	fund	VERB
ajlm-1264	95	35	programme	programme	NOUN
ajlm-1264	95	36	(	(	PUNCT
ajlm-1264	95	37	p30	p30	NOUN
ajlm-1264	95	38	ai078498	ai078498	PROPN
ajlm-1264	95	39	)	)	PUNCT
ajlm-1264	95	40	.	.	PUNCT
ajlm-1264	96	1	data	datum	NOUN
ajlm-1264	96	2	availability	availability	NOUN
ajlm-1264	96	3	data	datum	NOUN
ajlm-1264	96	4	are	be	AUX
ajlm-1264	96	5	available	available	ADJ
ajlm-1264	96	6	from	from	ADP
ajlm-1264	96	7	(	(	PUNCT
ajlm-1264	96	8	1	1	X
ajlm-1264	96	9	)	)	PUNCT
ajlm-1264	96	10	clinical	clinical	ADJ
ajlm-1264	96	11	pharmacolog	pharmacolog	NOUN
ajlm-1264	96	12	quality	quality	NOUN
ajlm-1264	96	13	assurance	assurance	NOUN
ajlm-1264	96	14	program	program	NOUN
ajlm-1264	96	15	translational	translational	ADJ
ajlm-1264	96	16	pharmacology	pharmacology	NOUN
ajlm-1264	96	17	research	research	NOUN
ajlm-1264	96	18	core	core	NOUN
ajlm-1264	96	19	,	,	PUNCT
ajlm-1264	96	20	center	center	NOUN
ajlm-1264	96	21	for	for	ADP
ajlm-1264	96	22	integrated	integrate	VERB
ajlm-1264	96	23	global	global	ADJ
ajlm-1264	96	24	biomedical	biomedical	ADJ
ajlm-1264	96	25	sciences	science	NOUN
ajlm-1264	96	26	,	,	PUNCT
ajlm-1264	96	27	school	school	NOUN
ajlm-1264	96	28	of	of	ADP
ajlm-1264	96	29	pharmacy	pharmacy	NOUN
ajlm-1264	96	30	and	and	CCONJ
ajlm-1264	96	31	pharmaceutical	pharmaceutical	NOUN
ajlm-1264	96	32	sciences	science	NOUN
ajlm-1264	96	33	,	,	PUNCT
ajlm-1264	96	34	university	university	NOUN
ajlm-1264	96	35	at	at	ADP
ajlm-1264	96	36	buffalo	buffalo	PROPN
ajlm-1264	96	37	,	,	PUNCT
ajlm-1264	96	38	state	state	NOUN
ajlm-1264	96	39	university	university	PROPN
ajlm-1264	96	40	of	of	ADP
ajlm-1264	96	41	new	new	PROPN
ajlm-1264	96	42	york	york	PROPN
ajlm-1264	96	43	,	,	PUNCT
ajlm-1264	96	44	buffalo	buffalo	PROPN
ajlm-1264	96	45	,	,	PUNCT
ajlm-1264	96	46	new	new	PROPN
ajlm-1264	96	47	york	york	PROPN
ajlm-1264	96	48	,	,	PUNCT
ajlm-1264	96	49	united	united	PROPN
ajlm-1264	96	50	states	states	PROPN
ajlm-1264	96	51	,	,	PUNCT
ajlm-1264	96	52	(	(	PUNCT
ajlm-1264	96	53	2	2	X
ajlm-1264	96	54	)	)	PUNCT
ajlm-1264	96	55	international	international	ADJ
ajlm-1264	96	56	psl	psl	NOUN
ajlm-1264	96	57	,	,	PUNCT
ajlm-1264	96	58	school	school	NOUN
ajlm-1264	96	59	of	of	ADP
ajlm-1264	96	60	pharmacy	pharmacy	NOUN
ajlm-1264	96	61	,	,	PUNCT
ajlm-1264	96	62	university	university	NOUN
ajlm-1264	96	63	of	of	ADP
ajlm-1264	96	64	zimbabwe	zimbabwe	PROPN
ajlm-1264	96	65	college	college	PROPN
ajlm-1264	96	66	of	of	ADP
ajlm-1264	96	67	health	health	PROPN
ajlm-1264	96	68	sciences	sciences	PROPN
ajlm-1264	96	69	,	,	PUNCT
ajlm-1264	96	70	po	po	PROPN
ajlm-1264	96	71	box	box	PROPN
ajlm-1264	96	72	a178	a178	PROPN
ajlm-1264	96	73	,	,	PUNCT
ajlm-1264	96	74	avondale	avondale	PROPN
ajlm-1264	96	75	,	,	PUNCT
ajlm-1264	96	76	harare	harare	PROPN
ajlm-1264	96	77	,	,	PUNCT
ajlm-1264	96	78	zimbabwe	zimbabwe	NOUN
ajlm-1264	96	79	and	and	CCONJ
ajlm-1264	96	80	(	(	PUNCT
ajlm-1264	96	81	3	3	NUM
ajlm-1264	96	82	)	)	PUNCT
ajlm-1264	96	83	antiviral	antiviral	ADJ
ajlm-1264	96	84	pharmacology	pharmacology	NOUN
ajlm-1264	96	85	laboratory	laboratory	NOUN
ajlm-1264	96	86	,	,	PUNCT
ajlm-1264	96	87	university	university	PROPN
ajlm-1264	96	88	of	of	ADP
ajlm-1264	96	89	nebraska	nebraska	PROPN
ajlm-1264	96	90	medical	medical	ADJ
ajlm-1264	96	91	center	center	PROPN
ajlm-1264	96	92	,	,	PUNCT
ajlm-1264	96	93	omaha	omaha	PROPN
ajlm-1264	96	94	,	,	PUNCT
ajlm-1264	96	95	nebraska	nebraska	PROPN
ajlm-1264	96	96	,	,	PUNCT
ajlm-1264	96	97	united	united	PROPN
ajlm-1264	96	98	states	states	PROPN
ajlm-1264	96	99	.	.	PUNCT
ajlm-1264	97	1	disclaimer	disclaimer	VERB
ajlm-1264	97	2	the	the	DET
ajlm-1264	97	3	content	content	NOUN
ajlm-1264	97	4	is	be	AUX
ajlm-1264	97	5	solely	solely	ADV
ajlm-1264	97	6	the	the	DET
ajlm-1264	97	7	responsibility	responsibility	NOUN
ajlm-1264	97	8	of	of	ADP
ajlm-1264	97	9	the	the	DET
ajlm-1264	97	10	authors	author	NOUN
ajlm-1264	97	11	and	and	CCONJ
ajlm-1264	97	12	does	do	AUX
ajlm-1264	97	13	not	not	PART
ajlm-1264	97	14	necessarily	necessarily	ADV
ajlm-1264	97	15	represent	represent	VERB
ajlm-1264	97	16	the	the	DET
ajlm-1264	97	17	official	official	ADJ
ajlm-1264	97	18	views	view	NOUN
ajlm-1264	97	19	of	of	ADP
ajlm-1264	97	20	the	the	DET
ajlm-1264	97	21	united	united	PROPN
ajlm-1264	97	22	states	states	PROPN
ajlm-1264	97	23	national	national	PROPN
ajlm-1264	97	24	institutes	institutes	PROPN
ajlm-1264	97	25	of	of	ADP
ajlm-1264	97	26	health	health	NOUN
ajlm-1264	97	27	.	.	PUNCT
ajlm-1264	98	1	references	reference	NOUN
ajlm-1264	98	2	mtisi	mtisi	ADJ
ajlm-1264	98	3	tj	tj	NOUN
ajlm-1264	98	4	,	,	PUNCT
ajlm-1264	98	5	maponga	maponga	ADJ
ajlm-1264	98	6	c	c	NOUN
ajlm-1264	98	7	,	,	PUNCT
ajlm-1264	98	8	monera	monera	NOUN
ajlm-1264	98	9	-	-	PUNCT
ajlm-1264	98	10	penduka	penduka	PROPN
ajlm-1264	98	11	tg	tg	PROPN
ajlm-1264	98	12	,	,	PUNCT
ajlm-1264	98	13	et	et	PROPN
ajlm-1264	99	1	al	al	PROPN
ajlm-1264	99	2	.	.	PUNCT
ajlm-1264	99	3	strategic	strategic	ADJ
ajlm-1264	99	4	establishment	establishment	NOUN
ajlm-1264	99	5	of	of	ADP
ajlm-1264	99	6	an	an	DET
ajlm-1264	99	7	international	international	ADJ
ajlm-1264	99	8	pharmacology	pharmacology	NOUN
ajlm-1264	99	9	specialty	specialty	NOUN
ajlm-1264	99	10	laboratory	laboratory	NOUN
ajlm-1264	99	11	in	in	ADP
ajlm-1264	99	12	a	a	DET
ajlm-1264	99	13	resource	resource	NOUN
ajlm-1264	99	14	-	-	PUNCT
ajlm-1264	99	15	limited	limit	VERB
ajlm-1264	99	16	setting	setting	NOUN
ajlm-1264	99	17	.	.	PUNCT
ajlm-1264	100	1	afr	afr	PROPN
ajlm-1264	100	2	j	j	PROPN
ajlm-1264	100	3	lab	lab	PROPN
ajlm-1264	100	4	med	med	PROPN
ajlm-1264	100	5	.	.	PUNCT
ajlm-1264	100	6	2018;7(1):a659	2018;7(1):a659	PROPN
ajlm-1264	100	7	.	.	PUNCT
ajlm-1264	101	1	https://doi.org/10.4102/ajlm.v7i1.659	https://doi.org/10.4102/ajlm.v7i1.659	PROPN
ajlm-1264	101	2	makita	makita	PROPN
ajlm-1264	101	3	-	-	PUNCT
ajlm-1264	101	4	chingombe	chingombe	PROPN
ajlm-1264	101	5	f	f	NOUN
ajlm-1264	101	6	,	,	PUNCT
ajlm-1264	101	7	ocque	ocque	PROPN
ajlm-1264	101	8	aj	aj	PROPN
ajlm-1264	101	9	,	,	PUNCT
ajlm-1264	101	10	difrancesco	difrancesco	PROPN
ajlm-1264	101	11	r	r	NOUN
ajlm-1264	101	12	,	,	PUNCT
ajlm-1264	101	13	et	et	PROPN
ajlm-1264	101	14	al	al	PROPN
ajlm-1264	101	15	.	.	PROPN
ajlm-1264	101	16	development	development	PROPN
ajlm-1264	101	17	and	and	CCONJ
ajlm-1264	101	18	validation	validation	NOUN
ajlm-1264	101	19	of	of	ADP
ajlm-1264	101	20	a	a	DET
ajlm-1264	101	21	high	high	ADJ
ajlm-1264	101	22	performance	performance	NOUN
ajlm-1264	101	23	liquid	liquid	NOUN
ajlm-1264	101	24	chromatography	chromatography	NOUN
ajlm-1264	101	25	method	method	NOUN
ajlm-1264	101	26	to	to	PART
ajlm-1264	101	27	determine	determine	VERB
ajlm-1264	101	28	nevirapine	nevirapine	ADJ
ajlm-1264	101	29	in	in	ADP
ajlm-1264	101	30	plasma	plasma	NOUN
ajlm-1264	101	31	in	in	ADP
ajlm-1264	101	32	a	a	DET
ajlm-1264	101	33	resource	resource	NOUN
ajlm-1264	101	34	-	-	PUNCT
ajlm-1264	101	35	limited	limit	VERB
ajlm-1264	101	36	setting	setting	NOUN
ajlm-1264	101	37	.	.	PUNCT
ajlm-1264	102	1	afr	afr	PROPN
ajlm-1264	102	2	j	j	PROPN
ajlm-1264	102	3	lab	lab	PROPN
ajlm-1264	102	4	med	med	PROPN
ajlm-1264	102	5	.	.	PUNCT
ajlm-1264	103	1	2019;8(1):a880	2019;8(1):a880	NUM
ajlm-1264	103	2	.	.	PUNCT
ajlm-1264	104	1	https://doi.org/10.4102/ajlm.v8i1.880	https://doi.org/10.4102/ajlm.v8i1.880	PROPN
ajlm-1264	104	2	bolaris	bolaris	PROPN
ajlm-1264	104	3	ma	ma	PROPN
ajlm-1264	104	4	,	,	PUNCT
ajlm-1264	104	5	keller	keller	PROPN
ajlm-1264	104	6	ma	ma	PROPN
ajlm-1264	104	7	,	,	PUNCT
ajlm-1264	104	8	robbins	robbins	PROPN
ajlm-1264	104	9	bl	bl	PROPN
ajlm-1264	104	10	,	,	PUNCT
ajlm-1264	104	11	podany	podany	VERB
ajlm-1264	104	12	at	at	ADP
ajlm-1264	104	13	,	,	PUNCT
ajlm-1264	104	14	fletcher	fletcher	PROPN
ajlm-1264	104	15	cv	cv	PROPN
ajlm-1264	104	16	.	.	PROPN
ajlm-1264	104	17	nevirapine	nevirapine	ADJ
ajlm-1264	104	18	plasma	plasma	NOUN
ajlm-1264	104	19	concentrations	concentration	NOUN
ajlm-1264	104	20	in	in	ADP
ajlm-1264	104	21	human	human	ADJ
ajlm-1264	104	22	immunodeficiency	immunodeficiency	NOUN
ajlm-1264	104	23	virus	virus	NOUN
ajlm-1264	104	24	-	-	PUNCT
ajlm-1264	104	25	exposed	expose	VERB
ajlm-1264	104	26	neonates	neonate	NOUN
ajlm-1264	104	27	receiving	receive	VERB
ajlm-1264	104	28	high	high	ADJ
ajlm-1264	104	29	-	-	PUNCT
ajlm-1264	104	30	dose	dose	NOUN
ajlm-1264	104	31	nevirapine	nevirapine	ADJ
ajlm-1264	104	32	prophylaxis	prophylaxis	NOUN
ajlm-1264	104	33	as	as	ADP
ajlm-1264	104	34	part	part	NOUN
ajlm-1264	104	35	of	of	ADP
ajlm-1264	104	36	3	3	NUM
ajlm-1264	104	37	-	-	PUNCT
ajlm-1264	104	38	drug	drug	NOUN
ajlm-1264	104	39	regimen	regiman	NOUN
ajlm-1264	104	40	.	.	PUNCT
ajlm-1264	105	1	j	j	PROPN
ajlm-1264	105	2	pediatric	pediatric	ADJ
ajlm-1264	105	3	infect	infect	PROPN
ajlm-1264	105	4	dis	dis	PROPN
ajlm-1264	105	5	soc	soc	PROPN
ajlm-1264	105	6	.	.	PUNCT
ajlm-1264	106	1	2017	2017	NUM
ajlm-1264	106	2	mar	mar	PROPN
ajlm-1264	106	3	1;6(1):102–104	1;6(1):102–104	PROPN
ajlm-1264	106	4	.	.	PUNCT
ajlm-1264	107	1	https://doi.org/10.1093/jpids/piv084	https://doi.org/10.1093/jpids/piv084	PROPN
ajlm-1264	107	2	pav	pav	PROPN
ajlm-1264	107	3	jw	jw	PROPN
ajlm-1264	107	4	,	,	PUNCT
ajlm-1264	107	5	rowland	rowland	PROPN
ajlm-1264	107	6	ls	ls	PROPN
ajlm-1264	107	7	,	,	PUNCT
ajlm-1264	107	8	korpalski	korpalski	PROPN
ajlm-1264	107	9	dj	dj	PROPN
ajlm-1264	107	10	.	.	PUNCT
ajlm-1264	108	1	hplc	hplc	PROPN
ajlm-1264	108	2	-	-	PUNCT
ajlm-1264	108	3	uv	uv	NOUN
ajlm-1264	108	4	method	method	NOUN
ajlm-1264	108	5	for	for	ADP
ajlm-1264	108	6	the	the	DET
ajlm-1264	108	7	quantitation	quantitation	NOUN
ajlm-1264	108	8	of	of	ADP
ajlm-1264	108	9	nevirapine	nevirapine	ADJ
ajlm-1264	108	10	in	in	ADP
ajlm-1264	108	11	biological	biological	ADJ
ajlm-1264	108	12	matrices	matrix	NOUN
ajlm-1264	108	13	following	follow	VERB
ajlm-1264	108	14	solid	solid	ADJ
ajlm-1264	108	15	phase	phase	NOUN
ajlm-1264	108	16	extraction	extraction	NOUN
ajlm-1264	108	17	.	.	PUNCT
ajlm-1264	109	1	j	j	PROPN
ajlm-1264	109	2	pharm	pharm	PROPN
ajlm-1264	109	3	biomed	biome	VERB
ajlm-1264	109	4	anal	anal	NOUN
ajlm-1264	109	5	.	.	PUNCT
ajlm-1264	110	1	1999;20(1–2):91–98	1999;20(1–2):91–98	NUM
ajlm-1264	110	2	.	.	PUNCT
ajlm-1264	111	1	https://doi.org/10.1016/s0731-7085(98)00312-4	https://doi.org/10.1016/s0731-7085(98)00312-4	PROPN
ajlm-1264	111	2	fan	fan	PROPN
ajlm-1264	111	3	-	-	PUNCT
ajlm-1264	111	4	havard	havard	PROPN
ajlm-1264	111	5	p	p	PROPN
ajlm-1264	111	6	,	,	PUNCT
ajlm-1264	111	7	liu	liu	PROPN
ajlm-1264	111	8	z	z	PROPN
ajlm-1264	111	9	,	,	PUNCT
ajlm-1264	111	10	chou	chou	PROPN
ajlm-1264	111	11	m	m	PROPN
ajlm-1264	111	12	,	,	PUNCT
ajlm-1264	111	13	et	et	PROPN
ajlm-1264	111	14	al	al	PROPN
ajlm-1264	111	15	.	.	PUNCT
ajlm-1264	111	16	pharmacokinetics	pharmacokinetic	NOUN
ajlm-1264	111	17	of	of	ADP
ajlm-1264	111	18	phase	phase	NOUN
ajlm-1264	111	19	i	i	PRON
ajlm-1264	111	20	nevirapine	nevirapine	ADJ
ajlm-1264	111	21	metabolites	metabolite	NOUN
ajlm-1264	111	22	following	follow	VERB
ajlm-1264	111	23	a	a	DET
ajlm-1264	111	24	single	single	ADJ
ajlm-1264	111	25	dose	dose	NOUN
ajlm-1264	111	26	and	and	CCONJ
ajlm-1264	111	27	at	at	ADP
ajlm-1264	111	28	steady	steady	ADJ
ajlm-1264	111	29	state	state	NOUN
ajlm-1264	111	30	.	.	PUNCT
ajlm-1264	112	1	antimicrob	antimicrob	PROPN
ajlm-1264	112	2	agents	agents	PROPN
ajlm-1264	112	3	chemother	chemother	PROPN
ajlm-1264	112	4	.	.	PUNCT
ajlm-1264	113	1	2013	2013	NUM
ajlm-1264	113	2	may;57(5):2154–2160	may;57(5):2154–2160	NOUN
ajlm-1264	113	3	.	.	PUNCT
ajlm-1264	114	1	https://doi.org/10.1128/aac.02294-12	https://doi.org/10.1128/aac.02294-12	NOUN
ajlm-1264	114	2	swindells	swindell	NOUN
ajlm-1264	114	3	s	s	PART
ajlm-1264	114	4	,	,	PUNCT
ajlm-1264	114	5	ramchandani	ramchandani	X
ajlm-1264	114	6	r	r	NOUN
ajlm-1264	114	7	,	,	PUNCT
ajlm-1264	114	8	gupta	gupta	PROPN
ajlm-1264	114	9	a	a	PRON
ajlm-1264	114	10	,	,	PUNCT
ajlm-1264	114	11	et	et	PROPN
ajlm-1264	114	12	al	al	PROPN
ajlm-1264	114	13	.	.	PROPN
ajlm-1264	115	1	one	one	NUM
ajlm-1264	115	2	month	month	NOUN
ajlm-1264	115	3	of	of	ADP
ajlm-1264	115	4	rifapentine	rifapentine	NOUN
ajlm-1264	115	5	plus	plus	CCONJ
ajlm-1264	115	6	isoniazid	isoniazid	NOUN
ajlm-1264	115	7	to	to	PART
ajlm-1264	115	8	prevent	prevent	VERB
ajlm-1264	115	9	hiv	hiv	PROPN
ajlm-1264	115	10	-	-	PUNCT
ajlm-1264	115	11	related	relate	VERB
ajlm-1264	115	12	tuberculosis	tuberculosis	NOUN
ajlm-1264	115	13	.	.	PUNCT
ajlm-1264	116	1	n	n	PROPN
ajlm-1264	116	2	engl	engl	PROPN
ajlm-1264	116	3	j	j	PROPN
ajlm-1264	116	4	med	med	PROPN
ajlm-1264	116	5	.	.	PUNCT
ajlm-1264	117	1	2019;380:1001–1011	2019;380:1001–1011	X
ajlm-1264	117	2	.	.	PUNCT
ajlm-1264	118	1	httrps://doi.org/10.1056/nejmoa1806808	httrps://doi.org/10.1056/nejmoa1806808	PROPN
ajlm-1264	118	2	united	united	PROPN
ajlm-1264	118	3	states	states	PROPN
ajlm-1264	118	4	food	food	PROPN
ajlm-1264	118	5	and	and	CCONJ
ajlm-1264	118	6	drug	drug	NOUN
ajlm-1264	118	7	administration	administration	NOUN
ajlm-1264	118	8	.	.	PUNCT
ajlm-1264	119	1	guidance	guidance	NOUN
ajlm-1264	119	2	for	for	ADP
ajlm-1264	119	3	industry	industry	NOUN
ajlm-1264	119	4	:	:	PUNCT
ajlm-1264	119	5	bioanalytical	bioanalytical	ADJ
ajlm-1264	119	6	method	method	NOUN
ajlm-1264	119	7	validation	validation	NOUN
ajlm-1264	119	8	.	.	PUNCT
ajlm-1264	120	1	rockville	rockville	PROPN
ajlm-1264	120	2	,	,	PUNCT
ajlm-1264	120	3	md	md	PROPN
ajlm-1264	120	4	:	:	PUNCT
ajlm-1264	120	5	fda	fda	PROPN
ajlm-1264	120	6	;	;	PUNCT
ajlm-1264	120	7	2001	2001	NUM
ajlm-1264	120	8	.	.	PUNCT
ajlm-1264	121	1	nevirapine	nevirapine	PROPN
ajlm-1264	121	2	pk	pk	NOUN
ajlm-1264	121	3	fact	fact	NOUN
ajlm-1264	121	4	sheet	sheet	NOUN
ajlm-1264	121	5	[	[	NOUN
ajlm-1264	121	6	homepage	homepage	NOUN
ajlm-1264	121	7	on	on	ADP
ajlm-1264	121	8	the	the	DET
ajlm-1264	121	9	internet	internet	NOUN
ajlm-1264	121	10	]	]	PUNCT
ajlm-1264	121	11	.	.	PUNCT
ajlm-1264	122	1	2016	2016	NUM
ajlm-1264	123	1	[	[	X
ajlm-1264	123	2	cited	cite	VERB
ajlm-1264	123	3	2020	2020	NUM
ajlm-1264	123	4	mar	mar	PROPN
ajlm-1264	123	5	19	19	NUM
ajlm-1264	123	6	]	]	PUNCT
ajlm-1264	123	7	.	.	PUNCT
ajlm-1264	124	1	https://liverpool-hiv-hep.s3.amazonaws.com/prescribing_resources/pdfs/000/000/059/original/hiv_factsheet_nvp_2016_mar.pdf?1520612265	https://liverpool-hiv-hep.s3.amazonaws.com/prescribing_resources/pdfs/000/000/059/original/hiv_factsheet_nvp_2016_mar.pdf?1520612265	PROPN
ajlm-1264	124	2	clinical	clinical	ADJ
ajlm-1264	124	3	pharmacology	pharmacology	NOUN
ajlm-1264	124	4	quality	quality	NOUN
ajlm-1264	124	5	assurance	assurance	NOUN
ajlm-1264	124	6	,	,	PUNCT
ajlm-1264	124	7	proficiency	proficiency	NOUN
ajlm-1264	124	8	testing	testing	NOUN
ajlm-1264	124	9	unit	unit	NOUN
ajlm-1264	124	10	.	.	PUNCT
ajlm-1264	125	1	2019	2019	NUM
ajlm-1264	125	2	.	.	PUNCT
ajlm-1264	126	1	blind	blind	ADJ
ajlm-1264	126	2	nevirapine	nevirapine	ADJ
ajlm-1264	126	3	comparison	comparison	NOUN
ajlm-1264	126	4	report	report	NOUN
ajlm-1264	126	5	[	[	X
ajlm-1264	126	6	not	not	PART
ajlm-1264	126	7	published	publish	VERB
ajlm-1264	126	8	]	]	PUNCT
ajlm-1264	126	9	.	.	PUNCT